MRC Centre for Outbreak Analysis and Modelling Renewal
Lead Research Organisation:
Imperial College London
Abstract
The threat from new infectious diseases has been highlighted in recent years by the 2003 SARS epidemic, H5N1 'bird flu' and the 2009 H1N1 flu pandemic. Preparing for such eventualities is a priority for public health agencies and governments worldwide. Also, as scientific research delivers new approaches to controlling existing infectious diseases such as malaria, HIV and polio, there is a need to determine what interventions are likely to work best to limit the disease and illness caused by a specific disease in a particular setting.
In this context, computer modelling of the spread of diseases in populations coupled with scientifically rigorous data analysis have proven themselves as powerful tools for giving insight into how diseases spread and what can be done to limit that control that spread. The Centre for Outbreak Analysis and Modelling undertakes research on these scientific methods and applies them to disease threats of concern.
A key feature of the Centre is the close links it has made with with public health agencies - such as the UK Health Protection Agency, the Centers for Disease Control and Prevention in the US (CDC), and the World Health Organization (WHO) - organisations which have to formulate and implement strategies to control infectious diseases.
The senior scientists in the Centre are world-leaders in infectious disease modelling and analysis. They have broad experience in responding to real epidemics (e.g. BSE/vCJD, SARS, H5N1 bird flu and the 2009 flu pandemic), and undertaking epidemiological research on endemic diseases (such as malaria, HIV and polio). Their work directly influences disease control policy through the many interactions the Centre has with public health organisations and governments.
The funding provided by MRC and Imperial College have allowed dedicated investment into the development of close collaborative partnerships with HPA, CDC and WHO - as well as with other important organisations who work on improving health in developing countries (notably the Bill and Melinda Gates Foundation). With each, we are working on a large number of research projects which have both scientific interest to Centre researchers and are contributing to the evidence base needed for public health decisions. Centre funding supports a core technical capacity available to all projects, and pays for dedicated postdoctoral research staff who spend substantial time at WHO (Geneva) and CDC (Atlanta) undertaking epidemiological research with the staff of those agencies and facilitating collaboration with other Centre staff.
MRC funding has also facilitated a greater focus on collaboration, training and career development within the Centre - training the next generation of quantitative infectious disease epidemiologists. We are also involved in increasing knowledge of advanced modelling methods in public health institutions and the wider infectious disease research community, and so have run a number of introductory vocational short courses, both at Imperial College, but also on partner sites in Geneva and London.
All of this applied activity depends on the more fundamental research undertaken in the Centre on the epidemic dynamics of different diseases, how diseases evolve genetically over time, and on analysing new approaches to control or treat diseases. Much of this research is multidisciplinary, involving Centre researchers working with leading clinical and experimental scientists around the world.
Continued funding for the Centre will allow the collaborative partnerships established in the last 4 years to be sustained and enhanced, and new collaborations with researchers and health agencies in countries such as China and India to be developed. It will also fund new priority research areas, including work to implement the analysis and modelling methods developed by Centre staff as user-friendly computer programs that can be used by public health professionals around the world.
In this context, computer modelling of the spread of diseases in populations coupled with scientifically rigorous data analysis have proven themselves as powerful tools for giving insight into how diseases spread and what can be done to limit that control that spread. The Centre for Outbreak Analysis and Modelling undertakes research on these scientific methods and applies them to disease threats of concern.
A key feature of the Centre is the close links it has made with with public health agencies - such as the UK Health Protection Agency, the Centers for Disease Control and Prevention in the US (CDC), and the World Health Organization (WHO) - organisations which have to formulate and implement strategies to control infectious diseases.
The senior scientists in the Centre are world-leaders in infectious disease modelling and analysis. They have broad experience in responding to real epidemics (e.g. BSE/vCJD, SARS, H5N1 bird flu and the 2009 flu pandemic), and undertaking epidemiological research on endemic diseases (such as malaria, HIV and polio). Their work directly influences disease control policy through the many interactions the Centre has with public health organisations and governments.
The funding provided by MRC and Imperial College have allowed dedicated investment into the development of close collaborative partnerships with HPA, CDC and WHO - as well as with other important organisations who work on improving health in developing countries (notably the Bill and Melinda Gates Foundation). With each, we are working on a large number of research projects which have both scientific interest to Centre researchers and are contributing to the evidence base needed for public health decisions. Centre funding supports a core technical capacity available to all projects, and pays for dedicated postdoctoral research staff who spend substantial time at WHO (Geneva) and CDC (Atlanta) undertaking epidemiological research with the staff of those agencies and facilitating collaboration with other Centre staff.
MRC funding has also facilitated a greater focus on collaboration, training and career development within the Centre - training the next generation of quantitative infectious disease epidemiologists. We are also involved in increasing knowledge of advanced modelling methods in public health institutions and the wider infectious disease research community, and so have run a number of introductory vocational short courses, both at Imperial College, but also on partner sites in Geneva and London.
All of this applied activity depends on the more fundamental research undertaken in the Centre on the epidemic dynamics of different diseases, how diseases evolve genetically over time, and on analysing new approaches to control or treat diseases. Much of this research is multidisciplinary, involving Centre researchers working with leading clinical and experimental scientists around the world.
Continued funding for the Centre will allow the collaborative partnerships established in the last 4 years to be sustained and enhanced, and new collaborations with researchers and health agencies in countries such as China and India to be developed. It will also fund new priority research areas, including work to implement the analysis and modelling methods developed by Centre staff as user-friendly computer programs that can be used by public health professionals around the world.
Technical Summary
The threat to human populations from new and re-emerging pathogens has been highlighted in recent years by the 2003 SARS epidemic, the pandemic potential of the highly pathogenic H5N1 avian influenza strain and the 2009 H1N1 pandemic. Preparedness is therefore a key policy priority for public health agencies and governments worldwide. In addition, as novel vaccines, antimicrobials and other interventions are developed for endemic diseases, there is a need to extrapolate from clinical trial results to determine which combination of interventions gives the optimal (or most cost-effective) control strategy for a specific disease in a particular setting.
In this context, modern epidemiological modelling and analysis methods have proven themselves increasingly powerful tools for giving insight into the patterns of emergence of novel outbreaks, the transmission dynamics of endemic diseases and the options available for the control of both. In the last 4 years, the Centre for Outbreak Analysis and Modelling has facilitated the exploitation of cutting-edge quantitative epidemiological research by public health agencies and policy makers tasked with delivering response strategies to infectious disease threats.
Before the founding of the Centre, much of the interaction between the (world leading) researchers at the Centre and public health agencies (such as HPA, CDC or WHO) was sporadic and unsystematic, being difficult to fund from traditional project grants. Centre funding allows dedicated investment into the development and maintenance of close collaborative partnerships with HPA, CDC, WHO and BMGF. Centre funding supports a core technical capacity available to all projects, and pays for dedicated 'liaison' staff - postdocs who spend substantial time at WHO and CDC. Internally, Centre funding supports capacity-building, enhanced collaboration and an enhanced focus on career development - as well as vocational training of staff in public/global health agencies.
In this context, modern epidemiological modelling and analysis methods have proven themselves increasingly powerful tools for giving insight into the patterns of emergence of novel outbreaks, the transmission dynamics of endemic diseases and the options available for the control of both. In the last 4 years, the Centre for Outbreak Analysis and Modelling has facilitated the exploitation of cutting-edge quantitative epidemiological research by public health agencies and policy makers tasked with delivering response strategies to infectious disease threats.
Before the founding of the Centre, much of the interaction between the (world leading) researchers at the Centre and public health agencies (such as HPA, CDC or WHO) was sporadic and unsystematic, being difficult to fund from traditional project grants. Centre funding allows dedicated investment into the development and maintenance of close collaborative partnerships with HPA, CDC, WHO and BMGF. Centre funding supports a core technical capacity available to all projects, and pays for dedicated 'liaison' staff - postdocs who spend substantial time at WHO and CDC. Internally, Centre funding supports capacity-building, enhanced collaboration and an enhanced focus on career development - as well as vocational training of staff in public/global health agencies.
Planned Impact
As a translational research Centre, a key aspect of our primary mission is wider impact. Our goal is to improve public and global health decision making in relation to infectious disease control through the use of advanced statistical and mathematical modelling methods, with a particular emphasis on novel emerging infections or rapidly spreading disease outbreaks. We believe the only effective way of delivering on this goal is to form long-term collaborative partnerships with the leading public and global health organisations world-wide, providing analytical support and capacity building for those partners.
The 2009 H1N1 pandemic provided a concrete test of this vision. In the first few weeks of the pandemic, the Centre's response team rapidly scaled to involve over 30 staff, with individual components being led by Centre PIs, coordinated by the Director.
From the translational perspective, some of the most critical roles were the staff who acted as liaisons with our key public health partners (especially WHO and CDC), spending much of 2009 embedded in those organisations.
The success of this approach in 2009 has led us to formalise and extended this 'embedding' model of building collaborative partnerships. Following the pandemic, the Centre became the WHO Collaborating Centre for Infectious Disease Modelling, with a senior research fellow acting as our primary liaison with WHO. We have adopted a similar model with US CDC, with another senior postdoctoral researcher from the Centre is based in Atlanta for the majority of his time.
HPA has considerable modelling capacity itself (two groups, in Colindale and Porton Down), so the nature of its relationship with the Centre is rather different. The Colindale modelling unit is now headed by Dr Peter White, who splits his time between HPA (80%) and the MRC Centre at Imperial (20%), providing a natural bridge between us. Collaborative work with the Colindale group has increased dramatically over the last few years. The Centre also collaborates with and advises the Microbial Risk Assessment group at Porton Down, most notably on bioterrorism related topics.
A second important aspect of the relationship is coordination of parallel research efforts: the UK Dept of Health (DH) often calls upon HPA for quantitative analysis, and increasingly the MRC Centre is being called upon to either peer review this work or provide alternative independent analyses. As HPA evolves to become Public Health England, we expect this role to become more important.
Over the first term of the Centre we have also built close relationships with a number of other key global/public health bodies: BMGF, UNAIDS, European CDC, China CDC (on pandemic influenza) being just a few. Our relationship with BMGF is of particular strategic importance - both as a funder of Centre research, but more importantly as a key stakeholder in global health decision-making. The Centre's work on polio, malaria, HIV, dengue and influenza has been influential in shaping BMGF investment decisions.
In addition to formal research outputs, often the most important value we give to these organisations is advice provided from a dynamical modelling perspective. This analytical advisory role is multifaceted: from improving situational awareness in crises, advising on likely impact of interventions, undertaking rapid assessments of severity and disease burden, and advising on improving surveillance, study design and data capture systems.
Capacity building within our partner organisation is another priority, through informal skills transfer and formal training. The former occurs as a natural result of the degree of interaction, and for the latter we have run short (2-3 day) short courses on infectious disease modelling for WHO in Geneva (in 2010) and for CDC in Atlanta (in 2011, in collaboration with Harvard).
Attached letters of support from HPA, CDC, WHO and BMGF highlight the public health impact of the Centre.
The 2009 H1N1 pandemic provided a concrete test of this vision. In the first few weeks of the pandemic, the Centre's response team rapidly scaled to involve over 30 staff, with individual components being led by Centre PIs, coordinated by the Director.
From the translational perspective, some of the most critical roles were the staff who acted as liaisons with our key public health partners (especially WHO and CDC), spending much of 2009 embedded in those organisations.
The success of this approach in 2009 has led us to formalise and extended this 'embedding' model of building collaborative partnerships. Following the pandemic, the Centre became the WHO Collaborating Centre for Infectious Disease Modelling, with a senior research fellow acting as our primary liaison with WHO. We have adopted a similar model with US CDC, with another senior postdoctoral researcher from the Centre is based in Atlanta for the majority of his time.
HPA has considerable modelling capacity itself (two groups, in Colindale and Porton Down), so the nature of its relationship with the Centre is rather different. The Colindale modelling unit is now headed by Dr Peter White, who splits his time between HPA (80%) and the MRC Centre at Imperial (20%), providing a natural bridge between us. Collaborative work with the Colindale group has increased dramatically over the last few years. The Centre also collaborates with and advises the Microbial Risk Assessment group at Porton Down, most notably on bioterrorism related topics.
A second important aspect of the relationship is coordination of parallel research efforts: the UK Dept of Health (DH) often calls upon HPA for quantitative analysis, and increasingly the MRC Centre is being called upon to either peer review this work or provide alternative independent analyses. As HPA evolves to become Public Health England, we expect this role to become more important.
Over the first term of the Centre we have also built close relationships with a number of other key global/public health bodies: BMGF, UNAIDS, European CDC, China CDC (on pandemic influenza) being just a few. Our relationship with BMGF is of particular strategic importance - both as a funder of Centre research, but more importantly as a key stakeholder in global health decision-making. The Centre's work on polio, malaria, HIV, dengue and influenza has been influential in shaping BMGF investment decisions.
In addition to formal research outputs, often the most important value we give to these organisations is advice provided from a dynamical modelling perspective. This analytical advisory role is multifaceted: from improving situational awareness in crises, advising on likely impact of interventions, undertaking rapid assessments of severity and disease burden, and advising on improving surveillance, study design and data capture systems.
Capacity building within our partner organisation is another priority, through informal skills transfer and formal training. The former occurs as a natural result of the degree of interaction, and for the latter we have run short (2-3 day) short courses on infectious disease modelling for WHO in Geneva (in 2010) and for CDC in Atlanta (in 2011, in collaboration with Harvard).
Attached letters of support from HPA, CDC, WHO and BMGF highlight the public health impact of the Centre.
Organisations
- Imperial College London (Lead Research Organisation)
- University of KwaZulu-Natal (Collaboration)
- Baylor College of Medicine (Collaboration)
- PATH (Collaboration)
- Harvard University (Collaboration)
- Government of the Swiss Confederation (Collaboration)
- Malaria in Pregnancy Consortium (Collaboration)
- Johns Hopkins University (Collaboration)
- Indiana University (Collaboration)
- Pasteur Institute, Paris (Collaboration)
- Biotechnology and Biological Sciences Research Council (BBSRC) (Collaboration)
- Aarhus University (Collaboration)
- Ministry of Defence (Collaboration)
- Copenhagen Consensus Center (Collaboration)
- United States Agency for International Development (Collaboration)
- University of Maryland, College Park (Collaboration)
- Industrial University of Santander (Collaboration)
- UNIVERSITY OF GLASGOW (Collaboration)
- Emory University (Collaboration)
- London School of Hygiene and Tropical Medicine (LSHTM) (Collaboration)
- Drugs for Neglected Diseases initiative (DNDi) (Collaboration)
- Sanofi (United Kingdom) (Collaboration)
- National Institutes of Health (NIH) (Collaboration)
- Worldwide Antimalarial Resistance Network (Collaboration)
- European Centre for Disease Prevention and Control (ECDC) (Collaboration)
- PANGEA Consortium (Collaboration)
- Médecins Sans Frontières (MSF) (Collaboration)
- Medicines for Malaria Venture (MMV) (Collaboration)
- Penn State University (Collaboration)
- Global Fund to Fight AIDS, Tuberculosis and Malaria (Collaboration)
- UNIVERSITY OF EDINBURGH (Collaboration)
- Kenyan Institute for Medical Research (KEMRI) (Collaboration)
- International Society for Infectious Diseases (ISID) (Collaboration)
- GlaxoSmithKline (GSK) (Collaboration)
- PoPART Consortium (Collaboration)
- University of Bristol (Collaboration)
- Makerere University (Collaboration)
- London School of Economics and Political Science (University of London) (Collaboration)
- Murdoch University (Collaboration)
- Joint United Nations Programme on HIV/AIDS (UNAIDS) (Collaboration)
- Centers for Disease Control and Prevention (CDC) (Collaboration)
- National Institute for Biological Standards and Control (NIBSC) (Collaboration)
- IMPERIAL COLLEGE LONDON (Collaboration)
- Department For Environment, Food And Rural Affairs (DEFRA) (Collaboration)
- China Centre for Disease Control (Collaboration)
- Government of Saudi Arabia (Collaboration)
- UNIVERSITY OF YORK (Collaboration)
- National Environment Agency (Collaboration)
- QIMR Berghofer Medical Research Institute (Collaboration)
- HealthMap (Collaboration)
- Christian Medical College, Vellore (Collaboration)
- Healthsites.io (Collaboration)
- University of California, San Francisco (Collaboration)
- University of Warwick (Collaboration)
- Government of the UK (Collaboration)
- The Wellcome Trust Sanger Institute (Collaboration)
- University of Bamako (Collaboration)
- Guangzhou No. 12 People's Hospital (Collaboration)
- University of Hong Kong (Collaboration)
- University of Pittsburgh (Collaboration)
- Intellectual Ventures (United States) (Collaboration)
- Tan Tock Seng Hospital (Collaboration)
- Sanofi Pasteur MSD (Collaboration)
- University of Florida (Collaboration)
- University of Wisconsin-Madison (Collaboration)
- National Tuberculosis Institute (India) (Collaboration)
- Joint Programming Initiative on Antimicrobial Resistance (Collaboration)
- Academic Medical Center (Collaboration)
- PUBLIC HEALTH ENGLAND (Collaboration)
- International Epidemiologic Databases to Evaluate AIDS (IeDEA) (Collaboration)
- Wellcome Trust (Collaboration)
- Oxitec Ltd (Collaboration)
- FIND Diagnostics (India) (Collaboration)
- Biomedical Research and Training Institute (BRTI) (Collaboration)
- Hannover Medical School (Collaboration)
- National Institute of Health, Pakistan (Collaboration)
- University of Bern (Collaboration)
- Antigen Discovery Inc (Collaboration)
- Chinese Center for Disease Control and Prevention (China CDC) (Collaboration)
- Center for Infectious Disease Modeling and Analysis (Collaboration)
- University of Toronto (Collaboration)
- Swansea University (Collaboration)
- Kaiser Permanente Washington Health Research Institute (Collaboration)
- CLINTON HEALTH ACCESS INITIATIVE (Collaboration)
- National Center for Scientific and Technological Research (CNRST) (Collaboration)
- Centre for Infectious Disease Research in Zambia (Collaboration)
- Max Planck Society (Collaboration)
- Experimental Zooprophylactic Institute of the Venezie (Collaboration)
- Michigan State University (Collaboration)
- Jinan University (Collaboration)
- European Vaccine Initiative (EVI) (Collaboration)
- Stellenbosch University (Collaboration)
- University of Oxford (Collaboration)
- UNSW Sydney (Collaboration)
- Bill & Melinda Gates Foundation (Collaboration)
- Colombian Institute of Family Welfare (Collaboration)
- Public Health Institute of Malawi (Collaboration)
- HIV Monitoring Foundation (SHM) (Collaboration)
- World Health Organization (WHO) (Collaboration)
- University College London (Collaboration)
- Institute for Health Metrics and Evaluation (IHME) (Collaboration)
- University of Cambridge (Collaboration)
- University of North Carolina at Chapel Hill (Collaboration)
- Brown University (Collaboration)
- University of Wisconsin-Milwaukee (Collaboration)
- University of Washington (Collaboration)
- University of Liverpool (Collaboration)
Publications
Aguas R
(2013)
Feature selection methods for identifying genetic determinants of host species in RNA viruses.
in PLoS computational biology
Akbari OS
(2013)
A synthetic gene drive system for local, reversible modification and suppression of insect populations.
in Current biology : CB
Aldridge RW
(2015)
'Pre-entry screening for tuberculosis' commentary: authors' response.
in Pathogens and global health
Aldridge RW
(2016)
Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study.
in The Lancet. Infectious diseases
Aldridge RW
(2014)
Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis.
in The Lancet. Infectious diseases
Alizon S
(2013)
Within-host and between-host evolutionary rates across the HIV-1 genome.
in Retrovirology
| Guideline Title | "Estimating direct and indirect protection from influenza vaccination in the USA" (forthcoming) |
| Description | "Estimating direct and indirect protection from influenza vaccination in the USA" (forthcoming) for CDC (USA) containing information to be included in national messaging on vaccination |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Description | Advice to EU on H1N1 pandemic (ECDC, DG-SANCO) |
| Geographic Reach | Europe |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Advice to UK DH on pandemic planning via 'SPI' advisory committee |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Advice to UK DH on responding to the UK H1N1 pandemic |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Advice to US govt (White House, HHS, CDC) on pandemic planning |
| Geographic Reach | North America |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Advice to US govt (White House, HHS, CDC) on responding to the H1N1 pandemic |
| Geographic Reach | North America |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Advice to the World Health Organisation on the H1N1 pandemic |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | April 2017: Netherlands, audit of modelling activity by RIVM (Dutch Public Health Agency) |
| Geographic Reach | Europe |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Attendance at WHO policy meetings on anitmicrobial resistance and HIV prevention |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Attended Davos as one of three Imperial representatives (including Alice Ghast and Kieth Nions). Advice to policy makers |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | reputation (representing Imperial at global forum) |
| URL | https://youtu.be/Ws2VcwRFEIE |
| Description | Bill And Melinda Gates Strategy and Advisory Group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Influenced the development of grant policy |
| Description | CDC - Disease Severity |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | CHPR Serology Surveillance Flu Steering Group - 2013 |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Improved information with which to choose influenza vaccine strategies |
| Description | Cabinet Office Advisory Committee |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Commissioner on Lancet Commission for Global Surgery - 2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | Consise Steering Committee - 2013 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | More accurate assesment of influenza burden. |
| Description | Continuation from 2015 reporting on CRO work. Modelling being used to advocate for major policy shifts for TB control in the region, as used by WHO. |
| Geographic Reach | Asia |
| Policy Influence Type | Membership of a guideline committee |
| Description | Continue to have an impact on global polio policy |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Continued engagement with UNAIDS leaderships TH |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | _ |
| Description | Continued engagement with WHO leadership TH |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | _ |
| Description | Continued engagement with leadership at Bill & Melinda Gates Foundation TH |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | not known |
| Description | Continued engagment with the PEPFAR leadership TH |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | re-orientation of budgeting priorities -- but this is confidential stuff currently |
| Guideline Title | National Guideline on Treatment of Latent Tuberculosis Infection |
| Description | Contribution to NICE (The National Institute for Health and Care Excellence) Guidance on TB - 2015 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| URL | http://www.nice.org.uk/guidance/ng33/evidence/appendix-i-imperial-college-ltbi-treatment-report-30-a... |
| Description | Contributor to WHO research roadmap on Influenza |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Co-chaired one stream of WHO's periodic review of global influenza research priorities |
| URL | http://www.who.int/csr/research-and-development/r_d_blueprint_plan_of_action.pdf?ua+1 |
| Description | Contributor to WHO research roadmap on Zika |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Informed short term public health research priorities for responding to the Latin American Zika epidemic |
| URL | http://www.who.int/csr/research-and-development/r_d_zika_involvement/en/ |
| Description | Coordination of multi-country research on specific topics of interest to WHO (e.g. H1N1pdm infection) resulting in peer-reviewed publications MVK |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Description | Copenhagen Consensus -TB control in India |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | not yet known |
| Description | DEFRA - modelling |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | DH Flu colloquium led by SofS DH |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | DH Pandemic Influenza Scientific Advisory Group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Department of Health - SPI |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Department of Health Ebola modelling group (2014) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Provided expert advice on Ebola epidemic response in West Afica, and preparedness for the UK, to ensure that the UK Government is provided with a high standard of scientific advice to support the response in West Africa and preparedness for the UK. |
| Description | Development of platform RECON learn |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Description | EYE strategy subgroup for risk assessment (with WHO) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | EYE strategy subgroup for risk assessment (with WHO) - participation with other academics to provide advice (to policy makers) in WHO with the aim to influence policy and decision making |
| Description | Economic evaluation of London TB Find & Treat service (DH) |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | http://www.bmj.com/site/video/findandtreat.xhtml |
| Description | Economic modelling of TB in hard to reach groups |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | _ |
| Description | Eliminating Yellow fever Epidemics (EYE) WHO meeting |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | http://www.who.int/csr/disease/yellowfev/eye-strategy/en/ |
| Description | Elimination Scenario Planning (WHO Country Guidance Document) - 2013 |
| Geographic Reach | Africa |
| Policy Influence Type | Influenced training of practitioners or researchers |
| URL | http://www.who.int/malaria/publications/atoz/9789241507028/en/ |
| Description | Elimination Scenario Planning (WHO policy document) AG |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Description | Epi Et - and Field Epi Training Program (PHE/CDC courses). |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Helping to redesign teaching modules for these courses |
| Description | Estimating the epidemic potential of swine-origin H3N2v influenza virus - results presented during a briefing to the director of US CDC SC |
| Geographic Reach | North America |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | Evaluation of the London TB Find and Treat Project |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | not known |
| Description | Evidence Review Group on Malaria Burden Estimation (WHO committee) AG |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Global Fund - develop KPIs for GF |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Supported the Global Fund with the development of their Key Performance Indicators (KPIs) |
| Description | Global Fund - secure agreement on GF investment case |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Support for the Global Fund on their investment decisions |
| Description | Global Plan for Insecticide Resistance Management (GPIRM) - WHO AG |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Description | Global polio immunisation |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | H5N1 Surveillance & Monitoring in Poultry |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Home Office - Security and Identity |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | IVCC talk - Bhatt - (relating to decisions) - budgeting vector control . Effect of interventions |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | India National TB programme - Modelling in Support of the National Strategic plan |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | not known yet |
| Description | Infectious disease modelling short course - 2013 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Informed public health professionals: what infectious diseases modelling can and can not do; what its data requirements are; how to critically appraise models. |
| URL | http://www.infectiousdiseasemodels.org/ |
| Description | Investment Case for Global Fund 2017 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | TBC |
| URL | http://www.theglobalfund.org/documents/publications/other/Publication_InvestmentCase_Summary_en/ |
| Description | London TB Find and Treat service (Parliamentary Hearings) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| URL | http://www.publications.parliament.uk/pa/ld200809/ldhansrd/text/90630-0001.htm |
| Description | MERS-CoV collaboration |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Improvements in survival, morbidity or quality of life re MERS Co-V. |
| Description | Malaria Policy Advisory Committee |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Market and transmission dynamics for efficient procurement of second-line TB drugs (2014) |
| Geographic Reach | National |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Description | Measures of efficacy of anti-malaria interventions against malaria transmission |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | http://www.who.int/vaccine_research/malaria_malvac2010/en/index.html |
| Description | Member of the Scientific Programme Committee (CROI 'Conference on Retroviruses and Opportunistic Infections' 2016 Boston) - 2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Description | Membership in Core WHO Committee on the use of ART (2015) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| URL | http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?ua=1 |
| Description | Monitoring disappearence of polio type 2 globally, providing weekly analysis of data to "polio partners": Gates, WHO, CDC (April 2016) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | NERVTAG (New and Emerging Respiratory Virus Threats Advisory Group) - 2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | NICE revision of guidelines for TB control |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | http://www.nice.org.uk/nicemedia/live/11978/56320/56320.pdf |
| Description | NIH (Expert consultation on finding 'unknowing' HIV) - 2013 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Improved regulatory environment in HIV. |
| Description | Norwegian National Institute of Public Health consultation on learning the lessons on Ebola -2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | Numerous citations in UK DH, US DHHS and WHO planning documents |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | http://europepmc.org/abstract/MED/16642006 |
| Description | Older adult Polio vaccination & infection - 2013 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | no information |
| Description | Outbreak response for yellow feevr in Angola |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | http://apps.who.int/iris/bitstream/10665/246103/1/WHO-YF-ENB-16.2-eng.pdf |
| Description | Paper (PMID: 26093978) on new vaccine strategies to finish polio eradication led to introduction of vaccine campaigns by Global Polio Eradication Programme in Nigeria, Pakistan and Afghanistan |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Description | Participation in evidence review group at the World Health Organization. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | http://www.who.int/malaria/mpac/mpac-oct2017-erg-malaria-low-density-infections-session2.pdf?ua=1 |
| Description | Participation to the JMM (Joint Monitoring Mission) for the National Tuberculosis Programme assessment in India. Report availbale here: http://www.tbonline.info/media/uploads/documents/jmmdraft2015.pdf |
| Geographic Reach | National |
| Policy Influence Type | Citation in systematic reviews |
| URL | http://www.tbonline.info/media/uploads/documents/jmmdraft2015.pdf |
| Description | Polio immunisation plans |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | http://www.polioeradication.org |
| Description | PopART (citation in new WHO consolidated treatment and testing guidelines) - 2013 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | http://www1.imperial.ac.uk/departmentofmedicine/divisions/infectiousdiseases/infectious_diseases/hiv... |
| Description | Preparatory Meeting of the Global Fund Fifth Replenishment (2017-2019), 16-17 December 2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Guideline Title | Conditions for use of long-lasting insecticidal nets treated with a pyrethroid and piperonyl butoxide |
| Description | Presentation to WHO Expert Review Group on Bednets - 2016 |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in clinical guidelines |
| Impact | It is estimated that 68% of malaria deaths have been averted through use of bednets though there is increasing fear that the effectiveness of these nets is being reduced by the presence of mosquitoes resistant to insecticide. A new type of net is available that claims to overcome the problems of pyrethroid resistance but it much more expensive so it is unclear where and when control programmes should invest in this type of net. Our work was used to justify the current WHO policy for the use of these nets. |
| URL | http://www.who.int/malaria/publications/atoz/use-of-pbo-treated-llins-report-nov2015.pdf?ua=1 |
| Description | Providing direct technical support to Pakistan Ministry of Health and WHO |
| Geographic Reach | Asia |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Working with WHO and government offices to offer risk assessment and campaign planning for polio eradication |
| Description | Provision of malaria vaccine public health impact scenarios to WHO and GAVI - 2013 |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Description | Publication of journal article on increase to TB burden. Influencing global numbers and strategy |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Significant influence on global understanding of TB burden |
| URL | http://timesofindia.indiatimes.com/india/No-of-Indias-TB-patients-may-be-double-the-estimate-Lancet/... |
| Description | RCUK - Global Uncertainties |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Recommendation for the long-term vaccination strategy for YF informing SAGE decisions |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Description | Roundatable to discuss Bovine Tuberculosis with Michael Gove, MP Defra Secretary of State and George Eustice, MP Minister, Jan 2018 (Department of Environment Food and Rural Affairs) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | Scientific Committee for Advanced Data and Modelling - 2013 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Improved outbreak response policies for pandemic influenza. |
| URL | http://www.chp.gov.hk/en/sas2/101/110/108.html |
| Description | Seasonal Malaria Chemoprophylaxis (WHO policy document) AG |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Description | Serological Epidemiology of Influenza Steering Group - Health protection Agency |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Severity of influenza pandemics. To feed into WHO guidelines on influenza severity. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | http://www.who.int/influenza/en/ |
| Description | Sitting on the advisory committee of GORN. To inform and guide development of new tools for outbreak response |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | collaboration on tool development |
| Description | Source of scientific data on the impacts of badger culling CD |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Sources of HIV transmission in The Netherlands |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Improved knowledge amongst professional practitioners about the sources of HIV transmission in The Netherlands, which subsequently led to improvements in treatment, access to care, survival, morbidity and quality of life for people living with HIV in The Netherlands |
| Description | Spi-M committee |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| Impact | contribution to government Spi-M panel |
| URL | https://www.gov.uk/government/groups/scientific-pandemic-influenza-subgroup-on-modelling |
| Description | Study made with PHE on allocation of pre-exposure prophylaxis for HIV |
| Geographic Reach | National |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Study made with PHE on allocation of pre-exposure prophylaxis for HIV |
| Description | Technical assistance to WHO for WHO documentation (e.g., Weekly Epidemiologic Record publications) MVK |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Description | Technical expertise on WHO led teleconferences for influenza, yellow fever, meningitis, and other pathogens |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | information not provided |
| Description | The International Decision Support Initiative (iDSI) supprted by Bill & Melinda Gates Foundation |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | Towards the Elimination of Hepatitis B and C by 2030. The draft WHO Global Hepatitis Strategy, 2016-2021 and global elimination targets. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Description | Uptake of new molecular diagnostic tools for TB in India (2014) |
| Geographic Reach | National |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Description | WHO - Malaria Interventions |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO - Public Health Research Priority for Influenza |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | WHO - Technical Expert Group on Guideline Development |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Sought to influence the way WHO developed guidelines |
| Description | WHO Collaboration on Modelling Dengue Vaccines - Strategic Advisory Group of Experts (SAGE) - 2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | WHO Consultation on data sharing during public health emergencies; later included in WHO Guidelines on data sharing -2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | WHO Consultations on 2013 HIV testing and treatment guidelines CF |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO Ebola Response Group - 2014 |
| Geographic Reach | Africa |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Improvements in survival, morbidity or quality of life re Ebola. |
| URL | http://www.nejm.org/doi/full/10.1056/NEJMoa1411100?query=featured_home |
| Description | WHO Gave evidence to 7th Vector Control Advisory group - VCAG |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO Gave evidence to the World Health Organisation Expert Review Group on "Conditions for use of long-lasting insecticidal nets treated with a pyrethroid and piperonyl butoxide" |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| URL | http://www.who.int/malaria/publications/atoz/use-of-pbo-treated-llins/en/#202017 |
| Description | WHO Global Technical Strategy for Malaria, 2016-2030 (2015) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | http://www.who.int/malaria/areas/global_technical_strategy/en/; http://www.who.int/malaria/areas/global_technical_strategy/WHO_HTM_GMP_2014.11_eng.pdf?ua=1; |
| URL | http://www.who.int/malaria/areas/global_technical_strategy/en |
| Description | WHO Malaria Elimination Guidelines - 2014 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_12-6-2014-18-17-49 |
| Description | WHO Policy Recommendation for the RTS,S malaria vaccine (2015) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | http://www.who.int/immunization/policy/position_papers/malaria/en |
| Description | WHO SAGE Polio - 2013 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO and Wellcome Trust Joint Consultation on preparing for the next epidemic -2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | WHO public health research agenda for Influenza. Speaker for the modelling stream of these guidelines |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO recommnedations on 'Conditions for use of long-lasting insecticidal nets treated with a pyrethroid and piperonyl butoxide' (December 2015) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | http://www.who.int/malaria/publications/atoz/use-of-pbo-treated-llins-report-nov2015.pdf?ua=1 |
| Description | Work Foundation panel discussion on assessing work productivity of people working with HIV/AIDS. |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Economic |
| URL | http://theworkfoundation.com |
| Description | World Health Organisation Steering Committee for Global Malaria Technical Strategy - 2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| URL | http://www.who.int/malaria/areas/global_technical_strategy/steering_committee/en |
| Description | Yes - Ebola outbreak response in DRC |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| Description | Zoonoses Workshop - Tanzania - Feb 2016 - 25 attendees including policy makers |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Description | polio1 NG |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Description | polio2 NG |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | the Bovine TB Science Review Group, Wales |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | vCJD projections and modelling |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | A genealogical approach to tracking bacterial transmission (Xavier Didelot) |
| Amount | £403,170 (GBP) |
| Funding ID | MR/N010760/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2016 |
| End | 05/2019 |
| Description | AMZAC (Azithromycin for Seasonal Malaria Chemoprevention) (Lesong Conteh) |
| Amount | £146,860 (GBP) |
| Funding ID | ITDCZA2510 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2014 |
| End | 06/2017 |
| Description | An integrated approach to understand the emergence and spread of extensively resistant Gram-negative bacteria in China |
| Amount | £26,958 (GBP) |
| Funding ID | MR/P007597/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2016 |
| End | 08/2019 |
| Description | Analytic and sequencing tools for poliovirus environmental surveillance |
| Amount | £554,669 (GBP) |
| Funding ID | OPP1171890 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2017 |
| End | 05/2019 |
| Description | Assessing the impact of waning vaccine efficacy on malarial elimination using a population transmission model (Tom Churcher) |
| Amount | £61,597 (GBP) |
| Organisation | PATH |
| Department | PATH Malaria Vaccine Initiative |
| Sector | Charity/Non Profit |
| Country | Global |
| Start | 09/2016 |
| End | 11/2018 |
| Description | BBSRC: Analytical methodology to perform genome-wide association studies in bacteria (Xavier Didelot) |
| Amount | £170,226 (GBP) |
| Funding ID | BB/L023458/1 |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2014 |
| End | 10/2016 |
| Description | BGMF: Mathematical modelling of poliovirus transmission to support the endgame |
| Amount | £487,817 (GBP) |
| Funding ID | OPP1099374 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2013 |
| End | 04/2018 |
| Description | BGMF: Treat children in India for enteric infections to improve their response to oral poliovirus vaccine (expanded grant) |
| Amount | £1,890,389 (GBP) |
| Funding ID | OPP1039135 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2012 |
| End | 03/2017 |
| Description | BMGF HIV Modelling Consortium |
| Amount | £2,080,207 (GBP) |
| Funding ID | OPP1022972 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2010 |
| End | 09/2013 |
| Description | BMGF Malaria in Pregnancy (MiP) Consortium: Mathematical models to guide treatment and prevention strategies for P.falciparum malaria in pregnancy |
| Amount | £81,332 (GBP) |
| Funding ID | GATES FDN CONSORTIUM |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2010 |
| End | 10/2014 |
| Description | BMGF Project Grant: Vaccine Modelling Initiative (VMI) |
| Amount | £1,755,066 (GBP) |
| Funding ID | 705580-1 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2008 |
| End | 10/2014 |
| Description | BMGF: Application of mathematical models to guide and evaluate malaria control and elimination programs |
| Amount | £2,539,445 (GBP) |
| Funding ID | OPP1068440 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2013 |
| End | 12/2020 |
| Description | BMGF: Control of TB in India: developing analytical tools |
| Amount | £385,936 (GBP) |
| Funding ID | OPP1095710 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2013 |
| End | 10/2018 |
| Description | BMGF: HIV Modelling Consortium (renewal 2013) |
| Amount | £3,522,615 (GBP) |
| Funding ID | OPP1084364 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2013 |
| End | 07/2018 |
| Description | BMGF: Phylogenetics Networks to Address Transmission of HIV (PANGEA_HIV) |
| Amount | £226,449 (GBP) |
| Funding ID | OPP1084352 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2013 |
| End | 09/2017 |
| Description | BMGF: PreP - ARV-based HIV Prevention Technologies |
| Amount | £786,465 (GBP) |
| Funding ID | OPP1032254 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2011 |
| End | 10/2015 |
| Description | BMGF: The interaction between hormonal contraceptives and HIV risk |
| Amount | £331,798 (GBP) |
| Funding ID | OPP1067133 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2012 |
| End | 02/2015 |
| Description | BMGF: Treat children in India for enteric infections to improve their response to oral poliovirus vaccine |
| Amount | £61,482 (GBP) |
| Funding ID | OPP1036117 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2011 |
| End | 10/2013 |
| Description | Building International Collaborations on the Mathematical Modelling of Emerging Infectious Disease Threats (Neil Ferguson) |
| Amount | £49,657 (GBP) |
| Funding ID | P11329/DF118 |
| Organisation | Imperial College London |
| Department | Imperial College Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2008 |
| End | 12/2023 |
| Description | Building TRUST |
| Amount | £100,609 (GBP) |
| Funding ID | Sub Award No. 1800014 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 06/2015 |
| End | 06/2018 |
| Description | CAPS (Cooking and Pneumonia Study) (Lesong Conteh) |
| Amount | £24,526 (GBP) |
| Funding ID | MR/K006533/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2013 |
| End | 02/2017 |
| Description | CDC via Uni Mississippi Med Center: Applied research to address emerging public health priorities BAA FY2017-OADS-01 (Xavier Didelot) |
| Amount | £13,393 (GBP) |
| Funding ID | 66109970918 |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Sector | Public |
| Country | United States |
| Start | 08/2017 |
| End | 09/2018 |
| Description | Cost-effectiveness systematic screening and treatment of pregnant women by CHW (Lesong Conteh) |
| Amount | £167,022 (GBP) |
| Funding ID | 305662 |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 08/2012 |
| End | 05/2017 |
| Description | DFID/MRC/Wellcome Trust Joint Global Health Trials Scheme |
| Amount | £179,101 (GBP) |
| Funding ID | RF020305 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2014 |
| End | 10/2018 |
| Description | DH: EMIT |
| Amount | £94,640 (GBP) |
| Funding ID | RGS:103272 |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2011 |
| End | 09/2014 |
| Description | DH: Effectiveness for Testing for and Treatment for Latent TB (HALT Study) |
| Amount | £210,090 (GBP) |
| Funding ID | 015/0306 |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2012 |
| End | 06/2017 |
| Description | DH: Improving communication with the public about antivirals and vaccination during the next pandemic |
| Amount | £89,147 (GBP) |
| Funding ID | N/A |
| Organisation | Government of the UK |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2013 |
| End | 08/2015 |
| Description | Defining disease importation and target interventions from routine surveillance data (Tom Churcher) |
| Amount | £81,703 (GBP) |
| Funding ID | OPP1161898 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2016 |
| End | 04/2018 |
| Description | Defra: A study to examine the interactions between cattle and badgers. |
| Amount | £24,636 (GBP) |
| Funding ID | ZSL ref: N587 |
| Organisation | Department For Environment, Food And Rural Affairs (DEFRA) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2012 |
| End | 03/2015 |
| Description | Defra: Ecological and epidemiological effects of small-scale badger culling. |
| Amount | £15,733 (GBP) |
| Funding ID | SE3272 |
| Organisation | Department For Environment, Food And Rural Affairs (DEFRA) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2011 |
| End | 03/2013 |
| Description | Defra: Transmission modeling and cost-effectiveness analysis of cattle vaccination at a herd level |
| Amount | £481,855 (GBP) |
| Funding ID | SE3130 |
| Organisation | Department For Environment, Food And Rural Affairs (DEFRA) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2011 |
| End | 07/2014 |
| Description | Develop a novel, cost-effective, surveillance approach for malaria elimination through existing antenatal care platform |
| Amount | £56,962 (GBP) |
| Funding ID | GAT.2162-01585030-SUB |
| Organisation | PATH |
| Sector | Charity/Non Profit |
| Country | Global |
| Start | 02/2018 |
| End | 08/2018 |
| Description | Diversity and Phenotype of Artemisinin Resistance Mutations in Central Africa (AZra Ghani) |
| Amount | £13,785 (GBP) |
| Funding ID | 5104760 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 05/2016 |
| End | 05/2018 |
| Description | Dorothy Hodgkin Fellowship - Lucy Okell (Modelling the control of artemisinin-based antimalarial drug resistance) |
| Amount | £355,171 (GBP) |
| Funding ID | N/A |
| Organisation | The Royal Society |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2016 |
| End | 12/2020 |
| Description | EMPIRIE: European managment platform for emerging and re-emerging infectious diseases entities. |
| Amount | £890,687 (GBP) |
| Funding ID | 223498 |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 04/2009 |
| End | 04/2014 |
| Description | ERC: BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe) |
| Amount | £2,261,061 (GBP) |
| Funding ID | 339251 |
| Organisation | European Research Council (ERC) |
| Sector | Public |
| Country | Belgium |
| Start | 03/2014 |
| End | 03/2019 |
| Description | EU FP7: PREHDICT: Health Economic Modelling of PREvention Strategies for HPV-related diseases in European Countries |
| Amount | £301,527 (GBP) |
| Funding ID | 242061 |
| Organisation | European Commission |
| Department | Seventh Framework Programme (FP7) |
| Sector | Public |
| Country | European Union (EU) |
| Start | 04/2010 |
| End | 04/2013 |
| Description | EU FP7:PREDEMICS |
| Amount | £780,182 (GBP) |
| Funding ID | 278433 |
| Organisation | European Commission |
| Department | Seventh Framework Programme (FP7) |
| Sector | Public |
| Country | European Union (EU) |
| Start | 11/2011 |
| End | 10/2016 |
| Description | EU: Building an Integrated Genetic infectious disease epidemilogy approach (transferred to UCL) |
| Amount | £80,930 (GBP) |
| Funding ID | 260801-BIG_IDEA |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 11/2010 |
| End | 12/2015 |
| Description | Epidemiological analysis and mathematical modelling of poliovirus elimination and endgame vaccination strategies |
| Amount | £56,616 (GBP) |
| Funding ID | 2017/769688-0 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 11/2017 |
| End | 12/2017 |
| Description | Epidemiology, evolution and control of infectious (AZra Ghani) |
| Amount | £200,400 (GBP) |
| Funding ID | 102169/B/13/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2017 |
| End | 09/2023 |
| Description | Epidemiology, evolution and control of infectious diseases |
| Amount | £2,004,000 (GBP) |
| Funding ID | 105169/B/13/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2017 |
| End | 09/2023 |
| Description | Epstein Barr Virus: Many questions, few answers |
| Amount | £2,800 (GBP) |
| Funding ID | 536857 |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2016 |
| End | 01/2018 |
| Description | Evolution, transmission and diversification patterns of group B streptococci - Elita Jauneikaite Fellowship |
| Amount | £125,000 (GBP) |
| Funding ID | M683 |
| Organisation | Rosetrees Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2017 |
| End | 07/2023 |
| Description | Evolution, transmission and diversification patterns of group B streptococci - Elita Jauneikaite Fellowship |
| Amount | £125,000 (GBP) |
| Funding ID | M683 |
| Organisation | Stoneygate Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2017 |
| End | 07/2023 |
| Description | Gates: Modelling the impact of diagnostics in global health: The BMGF Diagnostics Consortium |
| Amount | £403,372 (GBP) |
| Funding ID | OPP1095124 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2013 |
| End | 02/2015 |
| Description | Geospatial modelling for malaria risk stratification and intervention targeting (Sam Bhatt) |
| Amount | £219,507 (GBP) |
| Funding ID | 1606H5002/JH6 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2016 |
| End | 08/2020 |
| Description | H99: IHI iSense internal funding. Digital Disease Detection. |
| Amount | £99,210 (GBP) |
| Funding ID | 161737 |
| Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 02/2016 |
| End | 04/2017 |
| Description | HC-HIV modeling activity |
| Amount | £156,940 (GBP) |
| Organisation | United States Agency for International Development |
| Sector | Public |
| Country | United States |
| Start | 05/2017 |
| End | 06/2018 |
| Description | HIV Prevention Trials Network (HPTN) |
| Amount | $784,089 (USD) |
| Funding ID | UM1 AI068619 |
| Organisation | Family Health International |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2015 |
| End | 11/2018 |
| Description | HMJF: Influenza severity in the US military/CONSISE |
| Amount | £125,923 (GBP) |
| Funding ID | Contract No. 775696 |
| Organisation | Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) |
| Sector | Academic/University |
| Country | United States |
| Start | 01/2013 |
| End | 09/2013 |
| Description | HPA: Evaluation of the TB Find and Treat Project |
| Amount | £129,932 (GBP) |
| Funding ID | DoH via HPA |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 12/2010 |
| End | 07/2017 |
| Description | Health economics of MDR TB testing in the UK - 2013 |
| Amount | £48,496 (GBP) |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2012 |
| End | 12/2013 |
| Description | IVCC (Liverpool School of Tropical Medicine and Hygiene) |
| Amount | £166,330 (GBP) |
| Organisation | Liverpool School of Tropical Medicine |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 05/2015 |
| End | 08/2017 |
| Description | Identification of factors promoting the emergence of pathogens with human pandemic potential with zoonotic background and related prevention strategies |
| Amount | £759,182 (GBP) |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 11/2011 |
| End | 04/2017 |
| Description | Impact of maternally derived antibodies and microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants |
| Amount | £204,213 (GBP) |
| Funding ID | JXR11990 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2015 |
| End | 07/2018 |
| Description | Imperial College Global Health Fellowship Scheme: Integration of Communicable and Infectious Disease Health Care in South Africa (Berkowitz, Natasha) |
| Amount | £70,409 (GBP) |
| Funding ID | 105603/Z/14/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 08/2016 |
| End | 08/2017 |
| Description | Imperial College Global HealthClinical Fellowship Scheme: Understanding HIV Epidemics, Disease Progression and Interventions towards Marginalised (Kyaw Min, Soe) |
| Amount | £58,967 (GBP) |
| Funding ID | 204834/Z/16/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 06/2017 |
| End | 06/2018 |
| Description | Imperial College JRF: The effects of mass drug administration on Schistosoma population dynamics (Poppy Lamberton) |
| Amount | £180,000 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 12/2012 |
| End | 11/2015 |
| Description | Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R01) |
| Amount | $754,023 (USD) |
| Funding ID | 1R01AI120913-01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 06/2015 |
| End | 06/2016 |
| Description | Improving the efficacy of malaria prevention in an insecticide resistant Africa (Tom Churcher) |
| Amount | £162,798 (GBP) |
| Funding ID | 200222/B/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2016 |
| End | 04/2019 |
| Description | Juior Research Fellowship - Hannah Slater (Modelling the spatial heterogeneity of malaria transmission and the impact of spatially targetted interventions to eliminate malaria) |
| Amount | £142,150 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 09/2016 |
| End | 09/2019 |
| Description | Junior Research Fellowship - Ilaria Dorigatti (Within-host dynamics of dengue virus pathogenesis and the human antibody response) |
| Amount | £150,510 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 09/2015 |
| End | 09/2018 |
| Description | Junior Research Fellowship - Rafal Mostowy (Understanding the contribution of horizontal exchange of genes to the evolution of antigenic diverity in bacteria) |
| Amount | £139,790 (GBP) |
| Organisation | Imperial College London |
| Department | Imperial College Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2016 |
| End | 09/2019 |
| Description | Laboratory Refurbishment Award |
| Amount | £249,139 (GBP) |
| Organisation | The Royal Society |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 12/2017 |
| Description | MIDAS 2: Models for synthesising molecular, clinical and epidemiological data, and translation to public health response (NIH) |
| Amount | £1,246,328 (GBP) |
| Funding ID | 1U01GM110721-01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 08/2014 |
| End | 05/2019 |
| Description | MIDAS Project with UC San Diego AntiViral Research Center (AVRC) |
| Amount | £38,355 (GBP) |
| Funding ID | 58214101 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 04/2014 |
| End | 05/2016 |
| Description | MIDAS: Modelling Epidemic Infectious Diseases Using Sequence Analysis (Erik Volz) |
| Amount | £184,667 (GBP) |
| Funding ID | 258162IMP |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 01/2016 |
| End | 05/2019 |
| Description | MMV: Modeling of different potential implementations of existing ACTs and other anti-malarial products in development." |
| Amount | £316,782 (GBP) |
| Funding ID | MMV AD-12-1400-03 |
| Organisation | Medicines for Malaria Venture (MMV) |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 09/2013 |
| End | 09/2016 |
| Description | MRC Centre Grant: Centre for Outbreak Analysis and Modelling |
| Amount | £1,933,493 (GBP) |
| Funding ID | G0600719 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2008 |
| End | 03/2013 |
| Description | MRC Centre Grant: Centre for Outbreak Analysis and Modelling (Renewal) |
| Amount | £2,092,163 (GBP) |
| Funding ID | MR/K010174/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2013 |
| End | 03/2018 |
| Description | MRC Centre Grant: Centre for Outbreak Analysis and Modelling - equipment supplement |
| Amount | £141,000 (GBP) |
| Funding ID | MR/K010174/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2014 |
| End | 03/2015 |
| Description | MRC Centre Renewal - Equipment Sub # 2 |
| Amount | £100,000 (GBP) |
| Funding ID | MR/K010174/1B |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2013 |
| End | 03/2018 |
| Description | MRC Fellowship - Bob Verity (Genetic data as a signal of changing malaria transmission) |
| Amount | £281,370 (GBP) |
| Funding ID | MR/N01507X/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2016 |
| End | 03/2019 |
| Description | MRC Fellowship - Michael White (Modelling the contribution of relapse infections to the epidemiology and control of Plasmodium vivax malaria) |
| Amount | £300,098 (GBP) |
| Funding ID | MR/L012170/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2014 |
| End | 02/2017 |
| Description | MRC Fellowship - Patrick Walker (Understanding trends towards malaria elimination in Western Kenya) |
| Amount | £299,834 (GBP) |
| Funding ID | MR/L012189/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2014 |
| End | 03/2017 |
| Description | MRC Fellowship: Assessing the impact of HIV-1 in the black Caribbean community in south London |
| Amount | £368,031 (GBP) |
| Funding ID | G0802431/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2009 |
| End | 09/2013 |
| Description | MRC Fellowship: Optimal trial design for a release of malaria-refractory transgenic mosquitoes (John Marshall) |
| Amount | £285,102 (GBP) |
| Funding ID | MR/J012254/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2012 |
| End | 09/2015 |
| Description | MRC Fellowship: Spatio-temporal dynamics of drug-resistant Plasmodium falciparum malaria in Africa: implications for public health (Lucy Okell) |
| Amount | £305,791 (GBP) |
| Funding ID | G1002387 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2011 |
| End | 09/2015 |
| Description | MRC Fellowship: Synthesising data from multiple spatial scales and levels of detail to improve malaria transmission model predictions (Jamie Griffin) |
| Amount | £418,907 (GBP) |
| Funding ID | G1002284 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2011 |
| End | 09/2015 |
| Description | MRC Methodology Fellowship K O'Reilly - 2013 (Development of statistical modelling framework to inform real-time immunization strategies for elimination of poliomyelitis and other diseases) |
| Amount | £407,785 (GBP) |
| Funding ID | MR/J014362/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2012 |
| End | 09/2016 |
| Description | MRC Methodology Fellowship: Understanding the spatial dynamics of poliomyelitis and improved planning and mass vaccination campaigns. |
| Amount | £407,784 (GBP) |
| Funding ID | MR/J14362/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2012 |
| End | 09/2016 |
| Description | MRC Population Health Science Fellowship: Evaluation of Interventions and Diagnostics of Neglected tropical Diseases in sub-Saharan Africa |
| Amount | £326,242 (GBP) |
| Funding ID | G0902130 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2010 |
| End | 08/2013 |
| Description | MRC Supplement to MRC Centre Award: A continental-scale simulator for modelling malaria eradication strategies |
| Amount | £280,558 (GBP) |
| Funding ID | G0600719 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2009 |
| End | 03/2013 |
| Description | MRC fellowship JM - 2013 |
| Amount | £285,102 (GBP) |
| Funding ID | MR/J012254/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2012 |
| End | 09/2015 |
| Description | MRC: Centre for Outbreak Analysis and Modelling - studentships |
| Amount | £360,512 (GBP) |
| Funding ID | 1U54GM088491-01 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2013 |
| End | 03/2019 |
| Description | MRC: Understanding herd immunity and incidence variation for rapidly evolving pathogens: influenza in England and Wales, 1986 to 2009 |
| Amount | £839,354 (GBP) |
| Funding ID | MR/J008761/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2013 |
| End | 05/2017 |
| Description | Mapping the risk of international infectious disease spread |
| Amount | £111,089 (GBP) |
| Funding ID | AID-OAA-F-16-00115 |
| Organisation | United States Agency for International Development |
| Sector | Public |
| Country | United States |
| Start | 09/2016 |
| End | 06/2018 |
| Description | Marie Curie Fellowship - Francois Blanquart (Predicting the evolution of resistance in streptococcus pneumoniae - H2020) |
| Amount | £144,781 (GBP) |
| Funding ID | 657768 |
| Organisation | Marie Curie |
| Department | Marie Curie Research Institute |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2015 |
| End | 05/2017 |
| Description | Marie Curie Fellowship - Rafal Mostowy (The role of recombination in the evolution and epidemiology of the bacterial pathogen streptoccus pneumoniae) |
| Amount | £164,152 (GBP) |
| Funding ID | 329515 |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 03/2013 |
| End | 03/2015 |
| Description | Maternal Flu Immunisation CRA |
| Amount | £7,004 (GBP) |
| Funding ID | EPIDZC14 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 09/2013 |
| End | 08/2014 |
| Description | Maximising the public health impact of new approaches to control malaria in pregnancy through the translation of evidence-based global policies to country level policies and plans. |
| Amount | £42,075 (GBP) |
| Funding ID | CSA-2014-276 |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 01/2016 |
| End | 12/2018 |
| Description | Modeling to Understand the Epidemiological Impact and Market Impact of Harmonized Regimens for MDR-TB |
| Amount | £30,828 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2014 |
| End | 03/2016 |
| Description | Modelling antimalarial target product profiles for reducing P. falciparum malaria transmission |
| Amount | £316,782 (GBP) |
| Funding ID | PO14/00561 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2013 |
| End | 02/2019 |
| Description | Modelling malaria transmission and control in the Democratic Republic of Congo (NIH-UNC) |
| Amount | £198,334 (GBP) |
| Funding ID | 5101262 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 03/2015 |
| End | 03/2019 |
| Description | Modelling the incremental value of alternative strategies to IPT for malaria in pregnancy |
| Amount | £38,527 (GBP) |
| Organisation | Jhpiego |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2015 |
| End | 08/2015 |
| Description | Modelling the potential impact of intermittent preventive treatment of malaria in pregnancy on antimalarial drug resistance |
| Amount | £99,998 (GBP) |
| Organisation | Royal Society of Medicine |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2016 |
| End | 08/2018 |
| Description | Multidisciplinary Studies of HIV/AIDS and Aging (R21) |
| Amount | £205,531 (GBP) |
| Funding ID | 1R21AG053093 - 01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 08/2016 |
| End | 04/2019 |
| Description | NIH MIDAS Initiative: Mathematical Models in the study of Infectious Disease spread and control (2009-14) |
| Amount | £768,126 (GBP) |
| Funding ID | 1U54GM088491-01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 06/2009 |
| End | 06/2014 |
| Description | NIH NIAD: New methods for the design and evaluation of large HIV prevention interventions |
| Amount | £111,000 (GBP) |
| Funding ID | 1R01AI112339-01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 05/2014 |
| End | 05/2018 |
| Description | NIH: Genetic epidemiology of malaria in the Democratic Republic of Congo |
| Amount | £300,000 (GBP) |
| Funding ID | 1R01AI107949-01A1 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 03/2015 |
| End | 03/2016 |
| Description | NIH: Methodologies and Formative Work for Combination HIV Prevention Approaches |
| Amount | £117,604 (GBP) |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 06/2014 |
| End | 02/2017 |
| Description | NIH: PopART-Phylogenetics |
| Amount | £83,044 (GBP) |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 05/2013 |
| End | 11/2018 |
| Description | NIH: PopART: Cluster randomized trial of the impact of a combination HIV prevention |
| Amount | £1,531,054 (GBP) |
| Funding ID | HPTN 071 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 09/2011 |
| End | 11/2018 |
| Description | NIH: Targeting Primary Infection with Antiretrovirals to Prevent Transmission |
| Amount | £165,096 (GBP) |
| Funding ID | 1R01 AI083059-01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 07/2009 |
| End | 07/2014 |
| Description | NIH: The immune landscape of human influenza in households, towns and cities in southern China |
| Amount | £212,974 (GBP) |
| Funding ID | 5R01TW008246-04 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 01/2011 |
| End | 08/2015 |
| Description | NIHR - Senior Investigators Award (budget uplift) |
| Amount | £45,000 (GBP) |
| Funding ID | P/O 427921 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2014 |
| End | 04/2018 |
| Description | NIHR HTA: The cost effectiveness of genetic markers for antibiotic resistance in tuberculosis. |
| Amount | £48,496 (GBP) |
| Funding ID | 10/96/01 |
| Organisation | National Institute for Health Research |
| Department | Health Technology Assessment Programme (HTA) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2011 |
| End | 12/2013 |
| Description | NIHR Senior Investigator Award |
| Amount | £120,000 (GBP) |
| Funding ID | P/O 427921 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2009 |
| End | 04/2021 |
| Description | NIHR: HPRU in Respiratory Infections at Imperial College London |
| Amount | £14,021 (GBP) |
| Funding ID | WHRR_P47123 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2014 |
| End | 03/2019 |
| Description | NIHR: Interferon gamma tests for the rapid identification of active tuberculosis disease |
| Amount | £79,228 (GBP) |
| Funding ID | 08/106/02 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2011 |
| End | 02/2015 |
| Description | NIHR: NIHR HPRU in Modelling Methodology |
| Amount | £4,234,300 (GBP) |
| Funding ID | HPRU-2012-10080 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2014 |
| End | 03/2020 |
| Description | NIHR: TB Reach: Improving the management and control of tuberculosis among hard to reach groups |
| Amount | £100,000 (GBP) |
| Funding ID | RP-PG-0407-10340 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2008 |
| End | 08/2013 |
| Description | NIHR: Targeting men for better sexual health: The Ballseye Programme |
| Amount | £73,171 (GBP) |
| Funding ID | RP-PG-0707-10208 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 02/2009 |
| End | 02/2014 |
| Description | NIHR: Validation of new technologies for diagnosis and treatment evaluation of tuberculosis |
| Amount | £49,000 (GBP) |
| Funding ID | 12/65/27 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2014 |
| End | 06/2018 |
| Description | Near-Infrared Spectroscopy: A One-Stop-Shop for Mosquito Epidemiological Monitoring (Tom Churcher) |
| Amount | £643,883 (GBP) |
| Funding ID | MR/P01111X/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 02/2020 |
| Description | Optimal spatial scales for deployment of multiple first line therapies for malaria |
| Amount | £105,750 (GBP) |
| Funding ID | RGF\EA\180225 |
| Organisation | Royal Society of Medicine |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2017 |
| End | 03/2021 |
| Description | PATH/MVI/Gates: Modelling the public health impact and cost-effectiveness of the RTS,S malaria vaccine in malaria endemic countries |
| Amount | £302,135 (GBP) |
| Funding ID | GAT.0888-07-06258-CRT |
| Organisation | Program for Appropriate Technology in Health (PATH) |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2013 |
| End | 12/2018 |
| Description | PATH/MVI: Measuring the population efficacy of TBIs - the Transmission Population Assay |
| Amount | £1,010,322 (GBP) |
| Funding ID | GAT.0888-11-06546-COL |
| Organisation | Program for Appropriate Technology in Health (PATH) |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2013 |
| End | 07/2016 |
| Description | Pathfinder: Experimental Human Challenge with Genetically Modified Commensals to Investigate Respiratory Tract Mucosal Immunity and Colonisation (Xavier Didelot) |
| Amount | £18,598 (GBP) |
| Funding ID | MR/N026993/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2017 |
| End | 07/2020 |
| Description | Phase variable epigenetic regulation in Firmicutes (Nick Croucher) |
| Amount | £298,700 (GBP) |
| Funding ID | RM33G0360 |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2016 |
| End | 12/2018 |
| Description | Population Effects of Antretroviral Therapy to Reduce HIV Transmission (PopART) - Health Economics |
| Amount | £13,115 (GBP) |
| Organisation | Government of the UK |
| Department | Department for International Development (DfID) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2015 |
| End | 07/2018 |
| Description | Population Effects of Antretroviral Therapy to Reduce HIV Transmission (PopART) - Health Economics |
| Amount | £451,028 (GBP) |
| Funding ID | PO15001410 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 05/2015 |
| End | 05/2018 |
| Description | Predicting the impact of insecticide resistance and new paradigms of vector control (Tom Churcher) |
| Amount | £161,331 (GBP) |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2015 |
| End | 02/2018 |
| Description | Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling & projections |
| Amount | £634,543 (GBP) |
| Funding ID | PO201153562 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 01/2015 |
| End | 12/2017 |
| Description | Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling & projections |
| Amount | £222,968 (GBP) |
| Funding ID | EIP/DFA/PG/ca12/18 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 01/2013 |
| End | 12/2014 |
| Description | Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling & projections (2018-2019) |
| Amount | £468,709 (GBP) |
| Funding ID | 2017/778519 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 01/2018 |
| End | 12/2019 |
| Description | Quantifying and preparing for the non-communicable disease burden in the ageing HIV-positive population in Kenya |
| Amount | £134,891 (GBP) |
| Funding ID | OISE-17-62962-1 |
| Organisation | United States President's Emergency Plan for AIDS Relief |
| Sector | Public |
| Country | United States |
| Start | 07/2017 |
| End | 09/2018 |
| Description | Quantifying future clinical burden of an ageing HIV-positive patient population: a modelling analysis for the USA and Italy |
| Amount | £110,000 (GBP) |
| Funding ID | 212011616 |
| Organisation | Gilead Sciences, Inc. |
| Sector | Private |
| Country | United States |
| Start | 04/2016 |
| End | 12/2016 |
| Description | RO1 - Statistical Models for Estimating and Projecting HIV/AIDS Epidemics (Jeff Eaton) |
| Amount | £11,080 (GBP) |
| Funding ID | 5776-ICS-DHHS-6664 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 08/2017 |
| End | 08/2018 |
| Description | Research Project Grant (R01) PA-07-070 |
| Amount | $122,980 (USD) |
| Organisation | National Institute of Allergy and Infectious Diseases (NIAID) |
| Sector | Public |
| Country | United States |
| Start | 08/2015 |
| End | 02/2016 |
| Description | Research and Development of Reconstructing HIV Epidemics from HIV Phylogenetics |
| Amount | £54,832 (GBP) |
| Funding ID | 340798 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 08/2015 |
| End | 02/2018 |
| Description | RooPfs (Can improved housing provide additional protection against clinical malaria over current practice? A household-randomised controlled trial) (Lesong Conteh) |
| Amount | £179,101 (GBP) |
| Funding ID | MR/M007383/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2014 |
| End | 10/2018 |
| Description | Royal Society University Research Fellowship: Mathematical Modelling of Human Contact Networks and Implications for Infectious Disease |
| Amount | £670,090 (GBP) |
| Funding ID | 516002.K5789/KK UF041279 |
| Organisation | Royal Society of Medicine |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2004 |
| End | 03/2013 |
| Description | Rush Foundation: Understanding Health Externalities in HIV Intervention To Inform Budget Allocation in Africa |
| Amount | £444,000 (GBP) |
| Organisation | Rush Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 07/2013 |
| End | 07/2016 |
| Description | Secretariat of the UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Amount | $559,766 (USD) |
| Funding ID | SIE/SIM/PG/MM/ca/14/20 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 01/2015 |
| End | 12/2016 |
| Description | Sir Henry Dale Fellowship - Nick Croucher (Evolutionary dynamics underlying pneumococcal genomic diversity) |
| Amount | £708,513 (GBP) |
| Funding ID | 104169/Z/14/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2014 |
| End | 09/2019 |
| Description | Sir Henry Wellcome Fellowship. Modelling the impact of HSV-2 interventions on HIV transmission in sub-Saharan Africa. |
| Amount | £245,383 (GBP) |
| Funding ID | WT082623 |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2008 |
| End | 02/2013 |
| Description | Spatial Uncertainty: Data, Modeling, and Communication (R03) (Jeff Eaton) |
| Amount | £73,697 (GBP) |
| Funding ID | 1R03AI125001-01A1 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 12/2016 |
| End | 11/2018 |
| Description | Statistical model for SMFA precision (Tom Churcher) |
| Amount | £76,406 (GBP) |
| Funding ID | R0002102 MVI-SMFA |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2014 |
| End | 12/2015 |
| Description | Target Malaria - Controlling the mosquito vectors of malaria with engineered endonucleases |
| Amount | £238,798 (GBP) |
| Funding ID | OPP1141988 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2016 |
| End | 05/2020 |
| Description | The Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) Treatment for HIV |
| Amount | £177,479 (GBP) |
| Organisation | Viiv Healthcare |
| Sector | Private |
| Country | United Kingdom |
| Start | 05/2015 |
| End | 05/2016 |
| Description | The Interaction Between Hormonal Contraceptives and HIV Risk |
| Amount | £719,972 (GBP) |
| Funding ID | OPP1067133 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2012 |
| End | 02/2017 |
| Description | The delay-care cascade and its implications for TB transmission: a study in three country settings (Nim Pathy) |
| Amount | £70,160 (GBP) |
| Funding ID | STBP/USAID/GSA/92954/2017-21 |
| Organisation | United Nations Office for Project Services |
| Sector | Public |
| Country | United States |
| Start | 07/2017 |
| End | 02/2018 |
| Description | The evolution of influenza virus; Studies of within host and between host evolution to improve pandemic risk assessment and vaccine updates |
| Amount | £165,459 (GBP) |
| Funding ID | 200187/Z/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2016 |
| End | 03/2020 |
| Description | The global burden of Chikungunya virus |
| Amount | £290,652 (GBP) |
| Funding ID | MR/R024855/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2017 |
| End | 11/2020 |
| Description | The life course of human immune responses to influenza infection and vaccination |
| Amount | £1,882,747 (GBP) |
| Funding ID | 200861/Z/16/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2016 |
| End | 04/2021 |
| Description | UNAIDS: Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling & projections (extension) |
| Amount | £222,968 (GBP) |
| Funding ID | EIP/DFA/PG/ca12/18 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 01/2013 |
| End | 12/2014 |
| Description | Understanding Assays Used to Measure Malaria Transmission-Blocking Activity: Bridging Data Between the Laboratory and the Field |
| Amount | £79,079 (GBP) |
| Funding ID | IRD 304549/00 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 12/2013 |
| End | 07/2016 |
| Description | Vaccine Impact Modelling Consortium (VIMC) - Secretariat |
| Amount | £4,364,371 (GBP) |
| Funding ID | OPP1157270 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 12/2016 |
| End | 10/2022 |
| Description | Vaccine Impact Modelling Consortium (VIMC) - Sub-contracts |
| Amount | £4,788,528 (GBP) |
| Funding ID | PO008511 |
| Organisation | Bill and Melinda Gates Foundation |
| Department | Global Alliance for Vaccination and Immunisation (GAVI) |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 01/2017 |
| End | 08/2022 |
| Description | WHO Guidelines ARV Revision 2015 |
| Amount | £15,587 (GBP) |
| Funding ID | 2015/523611-0 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 01/2015 |
| End | 09/2016 |
| Description | WHO: Developing a model of the impact of artemisinin resistance |
| Amount | £27,990 (GBP) |
| Funding ID | PO 200833521 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 01/2013 |
| End | 12/2013 |
| Description | WHO: Economic appraisals of seasonal influenza vaccine in low & middle income countries (LMIC) - Work Package 3 |
| Amount | £7,000 (GBP) |
| Funding ID | EPIDZC14 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 09/2013 |
| End | 08/2014 |
| Description | WHO: Gut mucosal immunity induced by vaccine and wild-type poliovirus in India |
| Amount | £99,091 (GBP) |
| Funding ID | PO 200245063 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 07/2010 |
| End | 08/2013 |
| Description | WHO: HIV Modelling Consortium WHO Guidelines - 2013 |
| Amount | £62,836 (GBP) |
| Funding ID | HIV/SIP |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 09/2012 |
| End | 01/2013 |
| Description | WHO: Statistical and mathematical analysis of polio surveillance data to support the endgame |
| Amount | £218,091 (GBP) |
| Funding ID | 200953530 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 03/2014 |
| End | 12/2016 |
| Description | Wellcome Trust Collaborative Award |
| Amount | £165,459 (GBP) |
| Funding ID | 200187/Z/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 02/2016 |
| End | 01/2020 |
| Description | Wellcome Trust Fellowship - Epidemiology and evolution of pathogenic human enteroviruses - Margarita Pons Salort |
| Amount | £250,000 (GBP) |
| Funding ID | 106073/Z/14/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2015 |
| End | 02/2019 |
| Description | Wellcome Trust Fellowship: Merging theory and field studies for infectious disease dynamics |
| Amount | £581,029 (GBP) |
| Funding ID | 093488/Z/10/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2011 |
| End | 05/2016 |
| Description | Wellcome Trust Fellowship: The effect of population structure on the evolution and progression of infectious disease |
| Amount | £264,829 (GBP) |
| Funding ID | 091737/Z/10/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2011 |
| End | 01/2016 |
| Description | Wellcome Trust Fellowship: Uncovering Determinants of eco-evo Pathogen Dynamics with ABCì. |
| Amount | £250,000 (GBP) |
| Funding ID | 092311/Z/10/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2010 |
| End | 09/2014 |
| Description | Wellcome Trust Four-Year PhD Studentship - Miss Isobel Routledge |
| Amount | £165,784 (GBP) |
| Funding ID | 109310/Z/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2015 |
| End | 09/2019 |
| Description | Wellcome Trust Four-Year PhD Studentship - Mr Finlay Campbell |
| Amount | £165,784 (GBP) |
| Funding ID | 109159/Z/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2015 |
| End | 09/2019 |
| Description | Wellcome Trust Four-Year PhD Studentship - Mr Oliver J Watson |
| Amount | £165,784 (GBP) |
| Funding ID | 109312/Z/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2015 |
| End | 09/2019 |
| Description | Wellcome Trust Four-Year PhD Studentship - Mr Robin Maximillian Schaefer |
| Amount | £165,784 (GBP) |
| Funding ID | 109313/Z/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2015 |
| End | 09/2019 |
| Description | Wellcome Trust PhD Programme for Clinicians Fellowship for Bhargavi Rao: Artemisinin combination therapy and the health system |
| Amount | £245,728 (GBP) |
| Funding ID | 090791/Z/09/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2010 |
| End | 08/2013 |
| Description | Wellcome Trust: Studentship for Marcus Shepheard |
| Amount | £145,130 (GBP) |
| Funding ID | 083705/Z/07/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2007 |
| End | 07/2014 |
| Description | World Bank: Investigating reasons for epidemiological changes in HIV in African countries |
| Amount | £462,124 (GBP) |
| Funding ID | 7164102 |
| Organisation | World Bank Group |
| Sector | Public |
| Country | United States |
| Start | 07/2012 |
| End | 06/2016 |
| Description | Yellow Fever - Impact of immunisation in Africa |
| Amount | £117,089 (GBP) |
| Funding ID | OPP1117543 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2014 |
| End | 12/2016 |
| Description | Zika in Columbia: early characterisation of epidemiological potential |
| Amount | £149,824 (GBP) |
| Funding ID | MC_PC_15091 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2016 |
| End | 09/2017 |
| Description | Zika: A fast new intervention and an innovative method of evaluation (Tom Churcher) |
| Amount | £34,518 (GBP) |
| Funding ID | WPIA_P66851 |
| Organisation | QIMR Berghofer Medical Research Institute |
| Sector | Academic/University |
| Country | Australia |
| Start | 09/2016 |
| End | 12/2019 |
| Title | Platform RECON Learn |
| Description | Website for online training (RECON Learn) |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | Used in training |
| URL | https://reconlearn.netlify.com/ |
| Title | Climate data dataset |
| Description | Global climate data , different geographic resolutions to be used to inform models of dengue and other vector-borne diseases |
| Type Of Material | Database/Collection of data |
| Provided To Others? | No |
| Impact | Feeding into the dengue model, used to produce global risk maps of dengue infection |
| Title | Colombia - Chagas Costs (Colombia Chagas individual level provider treatment costs) |
| Description | The dataset comprises information of medical visits and costs of 7164 individuals with diagnosis of Chagas disease in Colombia between 2010-2014. The data was obtained from the Individual Registers for Health Services in Colombia at the Ministry of Health and integrated with four different dictionaries and algorithms to classify the stages of the disease and trajectories of care for this population. |
| Type Of Material | Database/Collection of data |
| Provided To Others? | No |
| Impact | No impact yet. Will be part of a publication and costs & CE eventually reported back to Colombian MoH. |
| Title | Colombia - Chagas Costs- Colombia Chagas individual level provider treatment costs |
| Description | The dataset comprises information of medical visits and costs of 7164 individuals with diagnosis of Chagas disease in Colombia between 2010-2014. The data was obtained from the Individual Registers for Health Services in Colombia at the Ministry of Health and integrated with four different dictionaries and algorithms to classify the stages of the disease and trajectories of care for this population. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | No |
| Impact | No impact yet (Will be part of a publication and costs & CE eventually reported back to Colombian MoH) |
| Title | Database from a systematic review on different diagnostics on malaria - 2015 |
| Description | Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | PMID: 26633770 |
| Title | Dataset from the EVI study |
| Description | Dataset on the correlates of immunogenicity for oral poliovaccines |
| Type Of Material | Database/Collection of data |
| Provided To Others? | No |
| Impact | Ability to predict vaccine response and effectiveness |
| Title | Discriminant Analysis of Principal Components (DAPC) |
| Description | a multivariate method designed to identify and describe clusters of genetically related individuals. When group priors are lacking, DAPC uses sequential K-means and model selection to infer genetic clusters. Our approach allows extracting rich information from genetic data, providing assignment of individuals to groups, a visual assessment of between-population differentiation, and contribution of individual alleles to population structuring. |
| Type Of Material | Data handling & control |
| Year Produced | 2010 |
| Provided To Others? | Yes |
| Impact | most highly accessed paper in BMC Genetics since its publication 6 weeks ago |
| Title | Ebola data analysis tools -2015 |
| Description | Wide range of statistical and modelling methods for the analysis of Ebola and other infectious disease outbreaks |
| Type Of Material | Data analysis technique |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | PMID: 25539446, 26029377 |
| Title | Estimating local chlamydia incidence and prevalence using surveillance data |
| Description | Synthesizes local surveillance data on rates of chlamydia testing and diagnosis with information on natural history |
| Type Of Material | Data analysis technique |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | Corresponding publication in press |
| Title | Estimating the reproduction number in real time CF |
| Description | Estimating the reproduction number in real time. Excel package and R package. Computer packages that will allow non-specialist to better analyse outbreaks |
| Type Of Material | Data analysis technique |
| Provided To Others? | No |
| Impact | Ready to be released, will be released with paper which is under review. Has been piloted during our 2 week short course, was very enthusiastically received |
| Title | Estimation of clearance rate of chlamydia |
| Description | synthesises data on rates of chlamydia clearance with different time-points to infer rates of clearance with greater precision |
| Type Of Material | Data analysis technique |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | Corresponding publication in press |
| URL | https://github.com/joanna-lewis/ct_clearance |
| Title | Exploration of the power of routine surveillance data to assess the impacts of industry-led badger culling on bovine tuberculosis incidence in cattle herds - 2015 |
| Description | How to assess the statistical power of testing for effects of badger culling |
| Type Of Material | Data analysis technique |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | PMID: 26374782 |
| Title | FluScape Project data set - 2015 |
| Description | The Fluscape cohort is a longitudinal cohort that looks at influenza infection in a detailed manner and pairs this with information on social contacts. By working on a fine geographical scale in a randomly selected communities with characterized contact patterns and immune profile, the Fluscape cohort attempts to relate the infection risk of individuals to their social contact patterns and to the connectivity of the community in which they live. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | Several publications and ongoing work |
| Title | Forecasting incidence |
| Description | Null model to predict future incidence |
| Type Of Material | Data analysis technique |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | Ability to produce better forecast data |
| Title | From malaria control to malaria elimination: a manual for elimination scenario planning - 2014 |
| Description | Computer software to evaluate the potential impact of malaria interventions in African countries |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2014 |
| Provided To Others? | Yes |
| Impact | The tool has been formally released as part of a WHO guidance document. It was applied in Rwanda in September 2014 as part of their assessment of the feasibility of malaria elimination |
| URL | http://www.who.int/malaria/publications/atoz/9789241507028/en/ |
| Title | Geograph R package |
| Description | Geograph is a framework for GIS analyses in R. A typical application would be computing friction routes. It is more flexible than any currently available GIS freeware and has some unique features, such as the ability to work on a spherical referential rather than 2D maps; this is important when working at large geographic scales as any 2D projection of the world (or large regions thereof) will lead to considerable deformation. |
| Type Of Material | Data analysis technique |
| Year Produced | 2009 |
| Provided To Others? | Yes |
| Impact | used for analysis of geographical data in 19586946 |
| Title | Global Dengue Transmission Map |
| Description | This publicly available web tool visualises by adm1 region estimates of dengue force of infection derived from age-stratified seroprevalence and incidence estimates. The webtool also calculates expected seroprevalence at each age, and the age at which a target seroprevalence is reached. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | This web tool was commissioned by and approved by the World Health Organization IVIR-AC committee and forms part of the official package of "tools to support decision-making for the addition of the licensed dengue vaccine into a public immunization programme" (http://www.who.int/immunization/research/development/dengue_serosurveys/en/) |
| URL | https://mrcdata.dide.ic.ac.uk/_dengue/dengue.php |
| Title | HBV model - 2016 |
| Description | A model that helps to evaluate HBV vaccination policy |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | A model that helps to evaluate impact of the current vaccination policy and to evaluate policy choices going forward for China CDC |
| Title | Hong Kong Flu Contacts - 2014 |
| Description | Contact and serological data form Hong Kong |
| Type Of Material | Database/Collection of data |
| Year Produced | 2014 |
| Provided To Others? | Yes |
| Impact | Too early to determine. |
| URL | http://rspb.royalsocietypublishing.org/content/281/1789/20140709/suppl/DC1 |
| Title | Imperial College/Public Health Foundation of India (ICPHFI) model for the TB epidemic in India - 2014 |
| Description | Model developed to capture the healthcare system in India, and TB transmission |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2014 |
| Provided To Others? | Yes |
| Impact | Model is being applied to address different questions of TB strategy, by PHFI colleagues |
| Title | Large scale kernels |
| Description | general method for fitting spatial processes with complete flexibility |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | 1 paper under revision |
| Title | Malaria - Housing Preference Dataset |
| Description | Xls / Stata, preferences of n=400 households who are recipients of the Roopfs housing intervention. Data base was generated through a cross-section survey among households receiving house improvements as part of a Randomized-controlled trial in The Gambia. They were asked about money spent on housing, about their satisfaction with the house (and its components) and about malaria perception, in addition to personal/socio-economic characteristics. |
| Type Of Material | Database/Collection of data |
| Provided To Others? | No |
| Impact | Analysis and publications in progress |
| Title | Malaria - Housing Preference Dataset. Roopfs Study - Housing Preferences in Rural Gambia |
| Description | Xls / Stata, preferences of n=400 households who are recipients of the Roopfs housing intervention. Data base was generated through a cross-section survey among households receiving house improvements as part of a Randomized-controlled trial in The Gambia. They were asked about money spent on housing, about their satisfaction with the house (and its components) and about malaria perception, in addition to personal/socio-economic characteristics. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | No |
| Impact | Analysis and publications in progress |
| Title | Malaria - SMC risk perception |
| Description | Xls / Stata, preferences of n=2000 respondents who are recipients of the Roopfs housing intervention. Data base was generated through a cross-section survey among households receiving SMC Randomized-controlled trial in Burkina Faso. |
| Type Of Material | Database/Collection of data |
| Provided To Others? | No |
| Impact | Analysis and publications in progress. |
| Title | Malaria - SMC risk perception SMC perceived malaria risk, migration& remittances - Burkina Faso & Mali |
| Description | Xls / Stata, preferences of n=2000 respondents who are recipients of the Roopfs housing intervention. Data base was generated through a cross-section survey among households receiving SMC Randomized-controlled trial in Burkina Faso. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | No |
| Impact | Analysis and publications in progress |
| Title | Malaria drug resistance mutations database |
| Description | Systematic review of sulphadoxine-pyrimethamine resistance in plasmodium falciparum |
| Type Of Material | Database/Collection of data |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | None yet. |
| Title | Meta analysis of impact of pyrethoid resistance on mosquito control |
| Description | Generated and analysed a database and provided raw data and analysis online |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | Provided online meta analysis of the impact of pyrethoid resistance on mosquito control |
| URL | https://elifesciences.org/content/5/e16090 |
| Title | Methods of determining Malaria elimination - 2014 |
| Description | method to determine whether malaria will be eliminated from a country if disease importation ceased |
| Type Of Material | Data analysis technique |
| Year Produced | 2014 |
| Provided To Others? | Yes |
| Impact | method is being discussed by WHO |
| URL | http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_12-6-2014-18-17-49 |
| Title | Model Library for TB models -2017 |
| Description | Library of curated TB models for use by students and collaborators |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | Used library to teach TB modelling to collaborators |
| Title | Model for estimating mutation frequencies in parasites |
| Description | R-code for estimating mutation frequencies from data on the prevalence of drug resistance in infected humans |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | None yet |
| Title | Montagu |
| Description | Vaccine impact estimates generated by the members of the VIMC specifying estimated disease burden for ten diseases in 98 low and middle income countries |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | No |
| Impact | Informing the funders regarding the impact of vaccination they fund |
| URL | https://montagu.vaccineimpact.org/ |
| Title | Outbreaks |
| Description | open data on outbreaks |
| Type Of Material | Database/Collection of data |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | over 500 downloads per month from predominantly external users |
| URL | http://www.repidemicsconsortium.org/outbreaks |
| Title | PCR data sets analysis improvement - 2015 |
| Description | PCR (polymerase chain reaction) data analysis technique normally does not have uncertainty around it, the new analysis technique generates 95% confidence intervals for quantitative PCR derived data. |
| Type Of Material | Data analysis technique |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | Paper published: "Improving statistical inference on pathogen densities estimated by quantitative molecular methods: malaria gametocytaemia as a case study" |
| Title | Patterns of TB care seeking in urban slums in India (The Foundation for Medical Research, India) - 2015 |
| Description | Arising from surveys in urban slums in India (in Patna and Mumbai), the database casts fresh light on the care seeking amongst TB patients in these areas. The surveys were conducted by the Foundation for Medical Research, and Dr. Pathy's involvement is to help them in its statistical analysis. |
| Type Of Material | Database/Collection of data |
| Provided To Others? | No |
| Impact | Performing statistical analysis for a paper to be published |
| Title | Providing quality of life estimates for people who live in Sub -Saharan Africa |
| Description | Parameter estimates for future studies |
| Type Of Material | Data analysis technique |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | Not yet |
| Title | Public Health England Serum Archive data - 2015 |
| Description | It is a database of anitbody titres for different influenza strains for anonymized samples collected in england and wales between 1999 and 2004 |
| Type Of Material | Database/Collection of data |
| Provided To Others? | No |
| Impact | Not published yet. |
| Title | Rakai dataset - 2016 |
| Description | Dataset with epidemiological information on HIV incident cases and HIV serodiscordent couples in the Rakai communities in Uganda |
| Type Of Material | Database/Collection of data |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | Publically available |
| URL | http://datadryad.org/resource/doi:10.5061/dryad.7kr85 |
| Title | SP resistance |
| Description | Systematic review of the prevalence of mutations associated with resistance to the antimalarial drug sulphadoxine-pyrimethamine. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | Shared with WHO and the Worldwide Antimalarial Resistance Network. |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/28785011 |
| Title | SeqTrack |
| Description | SeqTrack is an algorithm for reconstructing genealogies implemented in the adegenet package in the R environment |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2010 |
| Provided To Others? | Yes |
| Impact | none as yet |
| Title | Stacking |
| Description | ensemble method to combine metamodels |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | 2 pubs in Nature (IHME) and 1 pub in Royal Society Interface (IC) |
| Title | TB Burden inference through drug sales method |
| Description | TB Burden inference through drug sales method |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | IMS health using in collab with Gates foundation |
| URL | http://www.sciencedirect.com/science/article/pii/S1473309916302596 |
| Title | The role of rapid diagnostics in managing Ebola epidemics - 2015 |
| Description | Evaluating for optimal strategy in use of different forms of diagbostic tools |
| Type Of Material | Data analysis technique |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | Publically available analysis tools for download in Excel - PMID: 26633764 |
| Title | TransPhylo (2014) |
| Description | Software package for the Bayesian inference of infectious disease transmission from a phylogeny. The input is a dated phylogeny, where leaves correspond to pathogens isolated from the infected hosts. The main output is a transmission tree which indicates who infected whom. Such reconstruction can be achieved by colouring the branches of the phylogeny using a separate colour for each host, and such that the subtree coloured in a given colour represents the evolution happening within the corresponding host. Changes of colours on branches therefore correspond to transmission events from one host to another. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2014 |
| Provided To Others? | Yes |
| Impact | PMID 24714079 |
| URL | https://code.google.com/p/transphylo/ |
| Title | UK HIV Drug Resistance Sequences Database - 2015 |
| Description | Analysis of clinical and demographic patient data through 2012 |
| Type Of Material | Database/Collection of data |
| Provided To Others? | No |
| Impact | The HIV Drug Resistance Database provides a unique resource for molecular epidemiological studies of HIV transmission among more than 60 thousand patients diagnosed with HIV in the UK. The database contains unique information about risk factors for HIV transmission, and our group is developing and applying novel statistical approaches to mining this information with the ultimate goal of tailoring public health interventions to reduce transmission risk. |
| URL | http://www.hivrdb.org.uk/ |
| Title | Within-host model |
| Description | A within host model describing malaria parasites over time in patients, and the effects of drugs on them. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/29123086 |
| Title | World Development Indicators - 2015 |
| Description | In order to identify which determinants are most strongly associated with life expectancy, using extreme bound analysis technique applied to this publically available data set. |
| Type Of Material | Data analysis technique |
| Provided To Others? | No |
| Impact | Used for a forthcoming paper |
| URL | http://data.worldbank.org/data-catalog/world-development-indicators |
| Title | colgem - 2013 |
| Description | Software tool. 'Coalescent Liklihood for Generalized Epidemic Models'. This tool fits infectious disease models to pathogen genetic sequence data |
| Type Of Material | Data analysis technique |
| Provided To Others? | No |
| Impact | too early to know about this yet. |
| URL | https://code.google.com/p/colgem/ |
| Title | rcolgem - 2013 |
| Description | Software tool. This tool fits infectious disease models to pathogen genetic sequence data |
| Type Of Material | Data analysis technique |
| Year Produced | 2014 |
| Provided To Others? | Yes |
| Impact | currently being used by a researcher at Cambridge (vet. med) and Los Alamos Natl Laboratories. |
| URL | http://colgem.r-forge.r-project.org/ |
| Title | rcolgem - 2015 |
| Description | rcolgem statistical inference and modeling of genealogies generated by epidemic and ecological processes. It is a package for phylodynamic inference using population genetic models. rcolgem implements coalescent models for populations with nonlinear dynamics and potentially many demes. |
| Type Of Material | Data analysis technique |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | Used in various publications. For ex. http://www.ncbi.nlm.nih.gov/pubmed/26006189 |
| URL | http://colgem.r-forge.r-project.org |
| Description | An integrated approach to understand the emergence and spread of extensively resistant Gram-negative bacteria in China (UCL, Cambridge) |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical analysis of genomic data from E. coli and K. pneumoniae, especially isolates resistant to carbapenem |
| Collaborator Contribution | Sampling of isolates, whole-genome sequencing, in vitro experiments. |
| Impact | doi: https://doi.org/10.1101/220921 |
| Start Year | 2017 |
| Description | An integrated approach to understand the emergence and spread of extensively resistant Gram-negative bacteria in China (UCL, Cambridge) |
| Organisation | University of Cambridge |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical analysis of genomic data from E. coli and K. pneumoniae, especially isolates resistant to carbapenem |
| Collaborator Contribution | Sampling of isolates, whole-genome sequencing, in vitro experiments. |
| Impact | doi: https://doi.org/10.1101/220921 |
| Start Year | 2017 |
| Description | Armand Sprecher and Dirk Schumacher |
| Organisation | Médecins Sans Frontières (MSF) |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Developing model and r package for optimising contact tracing efforts |
| Collaborator Contribution | Formulating needs for contact tracing efforts during emergency outbreak response |
| Impact | r package Tracer has been published |
| Start Year | 2016 |
| Description | BEEHIVE - Academic Medical Centre -2013 |
| Organisation | HIV Monitoring Foundation (SHM) |
| Country | Netherlands |
| Sector | Charity/Non Profit |
| PI Contribution | BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe). Pilot feasibility study |
| Collaborator Contribution | AMC collected samples from Dutch hospitals, storing and documenting them prior to sending to Sanger |
| Impact | European Research Council have awarded a GBP £2m 'Advance Grant' to Imperial College for further research arising out of the pilot study. |
| Start Year | 2010 |
| Description | BEEHIVE - Wellcome Trust -2013 |
| Organisation | The Wellcome Trust Sanger Institute |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe). Pilot feasibility study |
| Collaborator Contribution | Sanger carried out genetic sequencing of samples and supplied the research data to Imperial and AMC. |
| Impact | European Research Council have awarded a GBP £2m 'Advance Grant' to Imperial College for further research arising out of the pilot study. |
| Start Year | 2010 |
| Description | BEEHIVE: Bridging the Evolution and Epidemiology of HIV in Europe (2014) |
| Organisation | Academic Medical Center |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Leadership & scientific coordination |
| Collaborator Contribution | Scientific collaboration; providing data, samples & laboratory analysis/work. |
| Impact | More cohorts involved than anticipated, but too early to report scientific impacts. |
| Start Year | 2011 |
| Description | BEEHIVE: Bridging the Evolution and Epidemiology of HIV in Europe (2014) |
| Organisation | The Wellcome Trust Sanger Institute |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Leadership & scientific coordination |
| Collaborator Contribution | Scientific collaboration; providing data, samples & laboratory analysis/work. |
| Impact | More cohorts involved than anticipated, but too early to report scientific impacts. |
| Start Year | 2011 |
| Description | Baylor College of Medicine |
| Organisation | Baylor College of Medicine |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Lead coordinator on a study and design of clinical study design |
| Collaborator Contribution | Rotavirus virology; mass spectrometry for breast milk study |
| Impact | N/A |
| Start Year | 2016 |
| Description | Baylor College of Medicine |
| Organisation | University of California, San Francisco |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Lead coordinator on a study and design of clinical study design |
| Collaborator Contribution | Rotavirus virology; mass spectrometry for breast milk study |
| Impact | N/A |
| Start Year | 2016 |
| Description | Biomedical Research and Training Institute (BRTI) |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Analysis |
| Collaborator Contribution | Field work |
| Impact | Grant |
| Start Year | 2017 |
| Description | Blue-Tongue Virus Modelling for UK |
| Organisation | Department For Environment, Food And Rural Affairs (DEFRA) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Provided support in model coding and development |
| Impact | Increased understanding of the dynamics and spread of Blue-Tongue virus in the UK. |
| Start Year | 2009 |
| Description | CDC - ABC (Active Bacterial Core surveillance) - Captain Matt Moore - 2015 |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Data analysis and modelling |
| Collaborator Contribution | Data interpretation and epidemiological analysis |
| Impact | Forthcoming publication |
| Start Year | 2015 |
| Description | CDC - Risk of air-travel spread of Yellow Fever Virus from Brazil into the United States |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Dr Ilaria Dorigatti conducted the analysis (i.e. developed the methodological framework and implemented the code used to generate the results), wrote the reports and communicated the results to the CDC. Prof Christl Donnelly and Dr Tini Garske provided feedback on the analysis and results and participated to the discussion with the CDC about the implications of the results. |
| Collaborator Contribution | The CDC provided the data necessary to conduct this research and useful discussion around the findings, which are currently being drafted in a publication on sustainable public health strategies involving vaccination that could avoid the introduction of Yellow Fever into the United States in future outbreaks. |
| Impact | This analysis has informed the CDC on potential strategies to adopt in the future to prevent Yellow Fever introduction into the US. A paper will be submitted for publication. |
| Start Year | 2017 |
| Description | CHAI - Taryn Barker |
| Organisation | Clinton Health Access Initiative |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Data analysis, guidance for programme operation |
| Collaborator Contribution | Provide data |
| Impact | 1 Manuscript under review - Journal TBC |
| Start Year | 2016 |
| Description | COSI |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | statistical analysis of swine influenza |
| Collaborator Contribution | access to data on swine influenza |
| Impact | project funded by the BBSRC, MRC, Wellcome Trust (who contributed equally to the costs). DEFRA have also provided support |
| Start Year | 2009 |
| Description | China CDC |
| Organisation | China Centre for Disease Control |
| Country | China |
| Sector | Public |
| PI Contribution | Statistical description of the H1N1 pandemic in China |
| Collaborator Contribution | We were provided access to data on the H1N1 pandemic in China and were able to gain an understanding of disease spread in this area of the world. |
| Impact | Publication submitted to The Lancet |
| Start Year | 2009 |
| Description | China CDC and China WHO |
| Organisation | Chinese Center for Disease Control and Prevention (China CDC) |
| Country | China |
| Sector | Public |
| PI Contribution | Modelling expertise |
| Collaborator Contribution | Provide data |
| Impact | 1 Manuscript under review - Journal TBC |
| Start Year | 2016 |
| Description | Collaborating Institute on Polio-2013 |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Data analysis and modelling |
| Collaborator Contribution | Polio data |
| Impact | An indirect consequence of this collaboration is that funding from the WHO has successfully been sought, after WHO based individuals at the Collaborating Institute on Polio suggested that we should apply for funding. Our subsequent application was successful (see 'Global Polio Eradication Initiative' under further funding). |
| Start Year | 2013 |
| Description | Collaboration with Univ of Pittsburgh (Don Burke) via NIH MIDAS network |
| Organisation | University of Pittsburgh |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | I developed pandemic influenza simulations for modelling intervention strategies |
| Collaborator Contribution | Collection of data, exchange of ideas, interaction with US policymakers |
| Impact | This work represented a major source of evidence to support pandemic preparedness work undertaken by the US, UK, WHO and other countries. Outputs were PubMed ID 16642006 and the following 2005 paper: Ferguson NM; Cummings DA; Cauchemez S; Fraser C; Riley S; Meeyai A; Iamsirithaworn S; Burke DS. (08 Sep 2005). Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 437:209-214. (PubMed ID 16079797) |
| Start Year | 2006 |
| Description | Combined Phylogenetic and Epidemiological Analysis in Seattle |
| Organisation | National Institutes of Health (NIH) |
| Country | United States |
| Sector | Public |
| PI Contribution | Nothing yet |
| Collaborator Contribution | Data collection in future |
| Impact | Nothing yet. |
| Start Year | 2014 |
| Description | Dengue Modelling Consortium JHU-2013 |
| Organisation | Johns Hopkins University |
| Department | Johns Hopkins Bloomberg School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Founder. Also one of three academic groups providing modelling and analysis of Sanofi Pasteur's dengue vaccine candidate. |
| Collaborator Contribution | Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate. |
| Impact | none yet |
| Start Year | 2013 |
| Description | Dengue Modelling Consortium SP-2013 |
| Organisation | Sanofi Pasteur MSD |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Founder. Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate. |
| Collaborator Contribution | Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate. |
| Impact | none yet |
| Start Year | 2013 |
| Description | Dengue Modelling Consortium UoF-2013 |
| Organisation | University of Florida |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Founder. Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate. |
| Collaborator Contribution | Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate. |
| Impact | none yet |
| Start Year | 2013 |
| Description | Dengue Modelling Consortium UoW-2013 |
| Organisation | University of Washington |
| Department | Department of Biostatistics |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Founder. Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate. |
| Collaborator Contribution | Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate. |
| Impact | none yet |
| Start Year | 2013 |
| Description | Department of Statistics Oxford Univ. Dino Sejdinovic |
| Organisation | University of Oxford |
| Department | Department of Statistics |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Research |
| Collaborator Contribution | Research |
| Impact | Special Statistics-paper under revision, Bhatt,2017 |
| Start Year | 2017 |
| Description | Dr Halimatou Diawara and Prof Alassane Dicko. |
| Organisation | University of Bamako |
| Department | Malaria Research and Training Centre (MRTC) Bamako |
| Country | Mali |
| Sector | Academic/University |
| PI Contribution | PhD supervisor |
| Collaborator Contribution | PhD supervisor, primary data collection, access to Malian health policy makers |
| Impact | forthcoming publications |
| Start Year | 2015 |
| Description | ECDC |
| Organisation | European Centre for Disease Prevention and Control (ECDC) |
| Country | Sweden |
| Sector | Public |
| PI Contribution | Review of the national and local experiences on school closures during the 2009 H1N1 pandemic |
| Collaborator Contribution | Access to data on school closures during the 2009 H1N1 pandemic for use in the development of new analysis tools and methods. |
| Impact | a manuscript is in preparation, presentation to ECDC |
| Start Year | 2010 |
| Description | ESP - 2015 |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Support for Elimination Scenario Planning exercises using modelling to support strategic planning in endemic countries |
| Collaborator Contribution | Support for the country process and provision of local data |
| Impact | Forthcoming |
| Start Year | 2015 |
| Description | Estimating burden of influenza in USA - 2014 |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Developing model to assist CDC in interpreting their surveillance systems |
| Collaborator Contribution | Providing data and expertise |
| Impact | Papers in progress: collaboration with public health officials at CDC |
| Start Year | 2013 |
| Description | Estimating burden of influenza in USA - 2014 |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Developing model to assist CDC in interpreting their surveillance systems |
| Collaborator Contribution | Providing data and expertise |
| Impact | Paper published, collaboraiton with public health officials at CDC |
| Start Year | 2013 |
| Description | Estimation of HIV transmission dynamics using genomic sequences-2013 |
| Organisation | Michigan State University |
| Department | Department of Community Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | All analysis of data first author on PMID: 22761556 |
| Collaborator Contribution | provision of anonymised data set. |
| Impact | PMID: 22761556 |
| Start Year | 2010 |
| Description | FIND Diagnostics India - 2015 |
| Organisation | FIND Diagnostics (India) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Contributed statistical analysis to "Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India" and led the modelling efforts for the publication "The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis" |
| Collaborator Contribution | Co-authored several papers |
| Impact | One paper published, one in review, and one in preparation stage. |
| Start Year | 2015 |
| Description | Flu Vaccination programme efficacy modelling-2013 |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Assessment of transmission model. |
| Collaborator Contribution | Assessment of transmission model. |
| Impact | Paper to report on this work is in publication. |
| Start Year | 2012 |
| Description | FluScape Liverpool (2014) |
| Organisation | University of Liverpool |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Helped to win grants and publish papers |
| Collaborator Contribution | Helped to win grants and publish papers |
| Impact | Several papers published. |
| Start Year | 2008 |
| Description | Fluscape GZ12 (2013) |
| Organisation | Guangzhou No. 12 People's Hospital |
| Country | China |
| Sector | Hospitals |
| PI Contribution | Analysis |
| Collaborator Contribution | Field work |
| Impact | none yet |
| Start Year | 2009 |
| Description | GAVI Alliance |
| Organisation | Bill and Melinda Gates Foundation |
| Department | Global Alliance for Vaccination and Immunisation (GAVI) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | (2016) Established Vaccine Impact Modelling Consortium to provide vaccine impact estimates to Gavi and improve used models. (2017) Gavi Alliance (yellow fever)/ Olivia Bullock (2016-Dec 2017) and now Holly Prudden (Since Jan 2018) |
| Collaborator Contribution | Provide funding and contacts to modelling groups |
| Impact | Montagu -delivery platform for vaccine impact estimates; vaccine impact estimates - still in progress - to have the full set of this update by the end of March - Funders will use these estimates for communication fundraising and shaping policy |
| Start Year | 2016 |
| Description | GFATM (Erik Volz consultancy) - 2015 |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling the impact of treatment-as-prevention on HIV in Nigeria and the role of concentrated transmission in high risk groups. |
| Collaborator Contribution | Provision of questions and data |
| Impact | Paper and a policy brief which are currently in review. |
| Start Year | 2015 |
| Description | GFATM - 2015 |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Collaboration on modelling malaria to inform the investment case, 2017-2022 strategy refresh and allocation formula |
| Collaborator Contribution | Provision of questions and data |
| Impact | Forthcoming |
| Start Year | 2015 |
| Description | GSK - 2013 |
| Organisation | GlaxoSmithKline (GSK) |
| Department | GSK Biologicals SA |
| Country | Belgium |
| Sector | Private |
| PI Contribution | Understanding biological mechanisms in the RTS,S vaccine and implications for public health impact |
| Collaborator Contribution | Provision of data from all Phase II studies |
| Impact | PMID 23613845; PMID 23454164, PMID 25012228; One submitted publication; Multiple conference presentations |
| Start Year | 2011 |
| Description | Global lineages |
| Organisation | The Wellcome Trust Sanger Institute |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Data analysis and laboratory work |
| Collaborator Contribution | Data provision |
| Impact | Publications |
| Start Year | 2012 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | Brown University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | Harvard University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | Indiana University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | International Epidemiologic Databases to Evaluate AIDS (IeDEA) |
| Country | Global |
| Sector | Charity/Non Profit |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | Ministry of Defence (MOD) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | University of Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | University of North Carolina at Chapel Hill |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Modelling Consortium (2014) |
| Organisation | University of York |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic. |
| Collaborator Contribution | Research activities in the mathematical modelling of the HIV epidemic. |
| Impact | Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic. |
| Start Year | 2010 |
| Description | HIV Monitoring Foundation - Prof Peter Reiss - 2015 |
| Organisation | HIV Monitoring Foundation (SHM) |
| Country | Netherlands |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling and phylogenetics |
| Collaborator Contribution | Clinical data and epidemiological monitoring |
| Impact | PMID: 26558543, 26529093, 26738795 |
| Description | HIV estimation in Europe |
| Organisation | Academic Medical Center |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | statistical and modelling techniques for estimating HIV transmission |
| Collaborator Contribution | access to data on HIV transmission in Europeaccess to data on HIV transmission in Europe |
| Impact | Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Hallett TB, Smit C, Garnett GP, de Wolf F. Sex Transm Infect. 2010 Jul 18. |
| Start Year | 2010 |
| Description | HIV estimation in Europe |
| Organisation | University of Bern |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | statistical and modelling techniques for estimating HIV transmission |
| Collaborator Contribution | access to data on HIV transmission in Europeaccess to data on HIV transmission in Europe |
| Impact | Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Hallett TB, Smit C, Garnett GP, de Wolf F. Sex Transm Infect. 2010 Jul 18. |
| Start Year | 2010 |
| Description | HPTN071 PopART |
| Organisation | PoPART Consortium |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Economic evaluation of the PopART intervention |
| Collaborator Contribution | Multi-disciplinary work with integrating an individual based disease transmission model |
| Impact | One pub in Lancet Global Health and others to be submitted soon |
| Start Year | 2012 |
| Description | Health Map |
| Organisation | HealthMap |
| Sector | Charity/Non Profit |
| PI Contribution | Gather data from various sources and build a model to estimate a risk of transmission of a pathogen from one country to another |
| Collaborator Contribution | Use model outputs to create maps and curate a website |
| Impact | N/A |
| Start Year | 2016 |
| Description | Healthsites.io |
| Organisation | Healthsites.io |
| Country | France |
| Sector | Private |
| PI Contribution | Gather data from various sources and build a model to estimate a risk of transmission of a pathogen from one country to another |
| Collaborator Contribution | Collect and provide data on healthcare facilities |
| Impact | N/A |
| Start Year | 2016 |
| Description | IHME |
| Organisation | Institute for Health Metrics and Evaluation (IHME) |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Research |
| Collaborator Contribution | Research |
| Impact | 2 papers accepted - Nature |
| Start Year | 2017 |
| Description | IRSS- Burkina Faso |
| Organisation | National Center for Scientific and Technological Research (CNRST) |
| Department | Institute of Research in Health Sciences |
| Country | Burkina Faso |
| Sector | Public |
| PI Contribution | PI on a succesful MRC programme grant investigating mosquito biology and evaluation of control interventions. Provided technical and analytical training to Burkinabe scientists |
| Collaborator Contribution | Field team in Burkina running major field component of an MRC programme grant |
| Impact | none yet |
| Start Year | 2017 |
| Description | IRSS- Institut de Recherche en Science de la Sante - Burkina Faso |
| Organisation | National Center for Scientific and Technological Research (CNRST) |
| Department | Institute of Research in Health Sciences |
| Country | Burkina Faso |
| Sector | Public |
| PI Contribution | PI on a succesful MRC programme grant investigating mosquito biology and evaluation of control interventions. Provided technical and analytical training to Burkinabe scientists |
| Collaborator Contribution | Nothing to report |
| Impact | Nothing to report |
| Start Year | 2017 |
| Description | Influenza in China |
| Organisation | China Centre for Disease Control |
| Country | China |
| Sector | Public |
| PI Contribution | Expertise in the epidemiological/statistical analysis and modelling of influenza. |
| Collaborator Contribution | Exchange of existing data and collection of new data on mobility in China |
| Impact | Exchange of existing data, collection of new data on mobility in China and building modelling capacity in China |
| Start Year | 2007 |
| Description | Influenza transmission in Singapore |
| Organisation | Tan Tock Seng Hospital |
| Country | Singapore |
| Sector | Hospitals |
| PI Contribution | Support for fellowship (mentor and collaborators) to develop and apply models of influenza transmission in Singapore. Also an on-going collaboration on STD modelling |
| Collaborator Contribution | provision of influenza data from Singapore. |
| Impact | Increased mathematical modelling capacity at the National University of Singapore |
| Start Year | 2009 |
| Description | Institut Pasteur - Herve Bourhy |
| Organisation | Pasteur Institute, Paris |
| Department | Laboratory Lysavirus Dynamics and Host Adaptation |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Analyse data |
| Collaborator Contribution | Provide data |
| Impact | Supervise an MSc student, workshop on rabies in Cameroon (Dec 2016) |
| Start Year | 2014 |
| Description | Institut Pasteur - Simon Cauchemez |
| Organisation | Pasteur Institute, Paris |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Analyse data on MERS-CoV virus |
| Collaborator Contribution | Analyse data on MERS-CoV virus |
| Impact | doi: 10.1073/pnas.1519235113 |
| Start Year | 2014 |
| Description | Institute for Disease Modelling in Seattle. Phil Ekhoff |
| Organisation | Intellectual Ventures |
| Country | United States |
| Sector | Private |
| PI Contribution | Bringing spatial expertise to outbreak mapping |
| Collaborator Contribution | Josh Procter and Phil Ekhoff. Core new method for outbreak mapping |
| Impact | Various presentations IVCC invited speaker. RBM. 1 paper under review submitted Nature Communications (still to be published) |
| Start Year | 2016 |
| Description | Institute of human virology - similar to global fund |
| Organisation | University of Maryland |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Modelling the impact of treatment-as-prevention on HIV in Nigeria and the role of concentrated transmission in high risk groups. |
| Collaborator Contribution | Modelling the impact of treatment-as-prevention on HIV in Nigeria and the role of concentrated transmission in high risk groups. |
| Impact | Paper and a policy brief which are currently in review. |
| Start Year | 2016 |
| Description | Ionnis Karagianis (coordinator) & Sam Bracebridge (Director) -Public Health England - for the Development of training material for outbreak response and field epidemiology (FETP) |
| Organisation | Public Health England |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Develop projects within the health protection research unit (HPRU) collaboration framework. Outbreak surveillance system and training platform for field epidemiologists |
| Collaborator Contribution | Provided expertise in development of projects |
| Impact | Creation of a new website for online training (RECON Learn) |
| Start Year | 2017 |
| Description | Javier Martin (Dr) |
| Organisation | National Institute for Biological Standards and Control (NIBSC) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Sequencing and analysis of polio virus in environmental samples |
| Collaborator Contribution | Virus isolation and sequencing |
| Impact | not yet |
| Start Year | 2017 |
| Description | LSHTM |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Department | Faculty of Epidemiology and Population Health |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | expertise in modelling the impact of school closure on influenza transmission |
| Impact | The impact of illness and the impact of school closure on social contact patterns. EAMES, K.T.; Tilston, N.L.; White, P.J.; Adams, E.; EDMUNDS, W.J.; Health Technol Assess, 2010; 14(34):267-312 NIHR grant awarded |
| Start Year | 2009 |
| Description | LSHTM - DPMB |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Department | Department of Pathogen Molecular Biology |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical analysis, writing publications |
| Collaborator Contribution | Data, scientific advice, contributing to publication. |
| Impact | Publication: https://www.ncbi.nlm.nih.gov/pubmed/28785011 |
| Start Year | 2013 |
| Description | LSHTM - malaria collaboration |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Department | Malaria Centre |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Advising on interpretation of transmission studies |
| Collaborator Contribution | Collected data |
| Impact | 1 Manuscript in review |
| Start Year | 2016 |
| Description | Lancet Commission on TB (UN, UCSF) |
| Organisation | University of California, San Francisco |
| Department | School of Medicine (UCSF) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Developed TB Modelling for three different countries in support of upcoming Lancet Commission on TB - which will result in a publication in the Lancet |
| Collaborator Contribution | Provide coordination between our modelling research and the rest of the commission |
| Impact | Two products - manuscript on TB modelling and a report by the Commission ( March - June 2018). |
| Start Year | 2017 |
| Description | Larry Liao - 2016 |
| Organisation | Jinan University |
| Country | China |
| Sector | Academic/University |
| PI Contribution | provision of samples |
| Collaborator Contribution | immuniological assays |
| Impact | no impacts yet |
| Start Year | 2016 |
| Description | MERS Coronovirus- Pasteur -2013 |
| Organisation | Pasteur Institute, Paris |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Assessing epidemic risk of MERS-CoV. Implications for health risk assessment and control. |
| Collaborator Contribution | Assessing epidemic risk of MERS-CoV. Implications for health risk assessment and control. |
| Impact | Corresponding publication. PMID 23787162 |
| Start Year | 2013 |
| Description | MERS Coronovirus- Saudi -2013 |
| Organisation | Government of Saudi Arabia |
| Country | Saudi Arabia |
| Sector | Public |
| PI Contribution | Assessing epidemic risk of MERS-CoV. Implications for health risk assessment and control. |
| Collaborator Contribution | Assessing epidemic risk of MERS-CoV. Implications for health risk assessment and control. |
| Impact | Corresponding publication. PMID 23787162 |
| Start Year | 2013 |
| Description | MERS-CoV collaboration - 2014 |
| Organisation | Government of Saudi Arabia |
| Country | Saudi Arabia |
| Sector | Public |
| PI Contribution | Epidemiological analysis and modelling of the MERS-Coronavirus epidemic in Saudi Arabia. |
| Collaborator Contribution | Access to data. Analysis and modelling. |
| Impact | Provided epidemiological analysis and modelling of the MERS-Coronavirus epidemic in Saudi Arabia. |
| Start Year | 2014 |
| Description | MERS-CoV collaboration - 2014 |
| Organisation | Johns Hopkins University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Epidemiological analysis and modelling of the MERS-Coronavirus epidemic in Saudi Arabia. |
| Collaborator Contribution | Access to data. Analysis and modelling. |
| Impact | Provided epidemiological analysis and modelling of the MERS-Coronavirus epidemic in Saudi Arabia. |
| Start Year | 2014 |
| Description | MIDAS with Pasteur (2014) |
| Organisation | Pasteur Institute, Paris |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Grant won from NIH |
| Collaborator Contribution | Co-wrote the grant application |
| Impact | None yet. |
| Start Year | 2013 |
| Description | MMV -2013 |
| Organisation | Medicines for Malaria Venture (MMV) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Development and application of models to consider the impact of and cost-effectiveness of switching to a new drug for first-line therapy in African countries (the impact of different anti-malarials as first-line therapy) |
| Collaborator Contribution | Provision of data, insight into appropriate questions |
| Impact | Paper in draft; Conference presentations at ASTMH 2012, Multilateral Initiative on Malaria Conference 2013 |
| Start Year | 2012 |
| Description | MSF - Malaria collaboration |
| Organisation | Médecins Sans Frontières (MSF) |
| Department | Médecins Sans Frontières Operational Centre Amsterdam (MSF OCA) |
| Country | Netherlands |
| Sector | Charity/Non Profit |
| PI Contribution | Co-supervising PhD looking into Malaria in humanitarian settings |
| Collaborator Contribution | Provided data and expertise |
| Impact | Training provided in malaria control to MSF country managers. |
| Start Year | 2016 |
| Description | MVI - 2013 |
| Organisation | European Vaccine Initiative (EVI) |
| Country | Germany |
| Sector | Charity/Non Profit |
| PI Contribution | Estimating the public health impact of the RTS,S vaccine and research into transmission-blocking vaccine measurement and trial design |
| Collaborator Contribution | Provision of data, discussion meetings |
| Impact | Paper in draft; Report to GAVI; Conference presentations at Multilateral Initiative on Malaria Conference 2013, Epidemics 2013 and ASTMH 2013 |
| Start Year | 2012 |
| Description | Malaria Atlas Project |
| Organisation | University of Oxford |
| Department | Big Data Institute |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Bringing spatial expertise to outbreak mapping |
| Collaborator Contribution | Data |
| Impact | NEJM - paper. Bhatt, S 2016. Nature- paper, Bhatt, 2017 |
| Start Year | 2016 |
| Description | Malawi Public Health Institute |
| Organisation | Public Health Institute of Malawi |
| Country | Malawi |
| Sector | Public |
| PI Contribution | Analyse data |
| Collaborator Contribution | Collect data |
| Impact | not yet |
| Start Year | 2018 |
| Description | Marc Lipsitch and Yonatan Grad (Harvard University) - 2015 |
| Organisation | Harvard University |
| Department | Harvard T.H. Chan School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Drug-resistance in gonorrhea: reviewing the literature, sythesising evidence, and identifying gaps in knowledge to propose a research agenda |
| Collaborator Contribution | All authors reviewed the literature, sythesised evidence, and identifed gaps in knowledge to propose a research agenda |
| Impact | PMID: 26518045 |
| Start Year | 2015 |
| Description | Marisa Miraldo - 2016 |
| Organisation | Imperial College London |
| Department | Department of Physics |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Managed the collaboration |
| Collaborator Contribution | Expertise in behavioral econ in designing and conducting flu vaccination study (PHE Porton Down) |
| Impact | Data from final survey awaited. Likelihood check. Then apply for grant in the future to expand detail and scale of experiment (including lab experiments) |
| Start Year | 2016 |
| Description | Mathematical models for Viet Nam & Cambodia to explore the impact of control measures to reduce the risk of H5N1 outbreaks in poultry |
| Organisation | Government of the UK |
| Department | Department for International Development (DfID) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Development and fitting of mathematical models to inform policy |
| Collaborator Contribution | Intellectual input |
| Impact | greater understanding of the impact of control measures on the spread of avian influenza. |
| Start Year | 2008 |
| Description | Mathematical models for the Swiss resurgent HIV epidemic |
| Organisation | Government of the Swiss Confederation |
| Department | Department of Public Health |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Development and fitting of models to inform policy |
| Collaborator Contribution | intellectual input |
| Impact | Increased understanding of the resurgence of HIV in Switzerland |
| Start Year | 2008 |
| Description | Matteo Gallizi (LSE) |
| Organisation | London School of Economics and Political Science (University of London) |
| Department | Department of Social Policy |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Managed the collaboration |
| Collaborator Contribution | Expertise in behavioural econ in designing and conducting flu vaccination study (PHE Porton Down). Experiments done in collaboration with Porton Down as well as independently with Matteo and Marisa and a PhD student |
| Impact | Data from final survey awaited. Likelihood check. Then apply for grant in the future to expand detail and scale of experiment (including lab experiments) Day-long PPI panel in September |
| Start Year | 2016 |
| Description | Medicines for Malaria Venture |
| Organisation | Medicines for Malaria Venture (MMV) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Developing models to answer questions posed by collaborator. |
| Collaborator Contribution | Ideas for research, scientific advice on research. |
| Impact | https://www.ncbi.nlm.nih.gov/pubmed/28814310 and https://www.ncbi.nlm.nih.gov/pubmed/29123086 |
| Start Year | 2013 |
| Description | Medicines for Malaria Venture - 2015 |
| Organisation | Medicines for Malaria Venture (MMV) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Mathematical modelling of impact of different anti-malerial drugs on transmission |
| Collaborator Contribution | Provide scientific advice and data, and funding |
| Impact | PMID: 25425081 |
| Start Year | 2013 |
| Description | Memorandum of Understanding with National Institute of Health - Colombia |
| Organisation | Colombian Institute of Family Welfare |
| Country | Colombia |
| Sector | Private |
| PI Contribution | Commitment to cooperative working and exchange of research in public health and education activities in science and technology. |
| Collaborator Contribution | Commitment to cooperative working and exchange of research in public health and education activities in science and technology. |
| Impact | Kelly Charniga funded by Imperial President Scholarship |
| Start Year | 2017 |
| Description | Methods for modelling transmission in households |
| Organisation | Harvard University |
| Department | Harvard T.H. Chan School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Development & fitting of mathematical models to inform policy |
| Collaborator Contribution | data sharing and intellectual input |
| Impact | data sharing and intellectual discourse |
| Start Year | 2009 |
| Description | Methods for using sequence data in epidemic models |
| Organisation | University of Edinburgh |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | mathematical modelling expertise |
| Impact | linking epidemiological data with human and pathogen genetic data |
| Start Year | 2009 |
| Description | MiP - 2014 |
| Organisation | Malaria in Pregnancy Consortium |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Continued collaboration modelling the impact of new strategies for reducing the burden of malaria in pregnancy |
| Collaborator Contribution | Modelling results |
| Impact | PMID: 25103519; PMID: 23511473 |
| Start Year | 2012 |
| Description | Miren Iturizza-Gomara (Prof-Mrs) University of Liverpool |
| Organisation | University of Liverpool |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Microbiome analysis |
| Collaborator Contribution | Provide rotavirus |
| Impact | 1 publication BMJ Open |
| Start Year | 2016 |
| Description | Modelling HIV evolution |
| Organisation | Johns Hopkins University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Development and fitting of mathematical models to better understand HIV evolution |
| Collaborator Contribution | Provision of data |
| Impact | 17954909 |
| Start Year | 2006 |
| Description | Modelling Influenza in the USA - 2013 |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Expertise in the epidemiological/statistical analysis and modelling of influenza. |
| Collaborator Contribution | Exchange of existing data and collaborative work on modelling disease trends. Collection of data on index patients and expertise in disease surveillance and influenza epidemiology |
| Impact | Exchange of existing data and collaborative work on modelling disease trends. |
| Start Year | 2007 |
| Description | Modernising Medical Microbiology 2013 and 2014 |
| Organisation | University of Oxford |
| Department | Nuffield Department of Clinical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical analysis of genomic data from Staphylococcus aureus and Clostridium difficile isolated from hospital settings, with the aim to improve our understanding of both evolution and epidemiology |
| Collaborator Contribution | Sampling of isolates and whole-genome sequencing. Expertise in clinical microbiology. |
| Impact | PMID 23259504, 23164609, 23204167, 23658690, 24066741, 24172133, 24853639, 24336451, 24433924, 25267672. This is a highly multi-disciplinary collaboration, connecting evolutionary biology, genomics, medical microbiology and epidemiology. PMID 28447949, 28130063, 28108681, 27427203 |
| Start Year | 2010 |
| Description | Murdoch University, Perth, Australia (Dr Xiaohui Zhang) - 2015 |
| Organisation | Murdoch University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Econometric analysis to determine the most important drivers of healthcare expenditure growth in OECD countries using a common factor model |
| Collaborator Contribution | Analysis |
| Impact | Paper forthcoming in the journal Health Economics. |
| Start Year | 2015 |
| Description | N95 respirators and Flu Transmission |
| Organisation | University of New South Wales |
| Department | School of Public Health and Community Medicine NSW |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Mathematical analysis of a randomized clinical trial |
| Collaborator Contribution | Our interaction with Prof MacIntyre has facilitated our research on the role of face masks and respirators in the prevention of influenza transmission. |
| Impact | MacIntyre CR; Wang Q; Cauchemez S; Seale H; Dwyer DE; Yang P; Shi W; Gao Z; et a; lPang X; Zhang Y; Wang X; Duan W; Rahman B; Ferguson N. (May 2011). A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respi Viruses. 5:170-179 |
| Start Year | 2011 |
| Description | NIH Pakistan |
| Organisation | National Institute of Health, Pakistan |
| Country | Pakistan |
| Sector | Public |
| PI Contribution | Analyse data |
| Collaborator Contribution | Provide sequencing data and surveillance data |
| Impact | N/A |
| Start Year | 2016 |
| Description | NIHR HPRU in Modelling Methodology at Imperial College London (2014) |
| Organisation | Public Health England |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Theme Leader on HIV & STIs Theme in NIHR HPRU in Modelling Methodology |
| Collaborator Contribution | Scientifc collaboration & data collection. |
| Impact | Too early to report scientific impacts. |
| Start Year | 2014 |
| Description | NIRS Queensland |
| Organisation | QIMR Berghofer Medical Research Institute |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Providing technical support and specialist knowledge |
| Collaborator Contribution | Data and field expertise |
| Impact | not known |
| Start Year | 2017 |